<SEC-DOCUMENT>0001104659-23-056001.txt : 20230504
<SEC-HEADER>0001104659-23-056001.hdr.sgml : 20230504
<ACCEPTANCE-DATETIME>20230504160629
ACCESSION NUMBER:		0001104659-23-056001
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230428
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230504
DATE AS OF CHANGE:		20230504

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyclacel Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001130166
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				911766850
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50626
		FILM NUMBER:		23888649

	BUSINESS ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922
		BUSINESS PHONE:		908-517-7330

	MAIL ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
		DATE OF NAME CHANGE:	20001218
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2314647d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:cycc="http://cyclacel.com/20230428">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_037_cycc_cyclacel.com_20230428 -->
<!-- Field: Set; Name: xdx; ID: xdx_04C_20230428_20230428 -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001130166 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_072_SO_T%2D%2D\DeptFiles%2DiXBRL 8%2DK Covers Templates\+++%2DROOT%2DElement%2D+++\DocumentInformationLineItems.xdxs -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-04-28to2023-04-28" name="dei:EntityCentralIndexKey">0001130166</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-04-28to2023-04-28" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="cycc-20230428.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-04-28to2023-04-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130166</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-28</xbrli:startDate>
        <xbrli:endDate>2023-04-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-282023-04-28_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130166</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-28</xbrli:startDate>
        <xbrli:endDate>2023-04-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-282023-04-28_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130166</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-28</xbrli:startDate>
        <xbrli:endDate>2023-04-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="text-align: center; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SECURITIES AND EXCHANGE
COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORM <span id="xdx_90D_edei--DocumentType_c20230428__20230428_zvkxKQBKwZ59"><ix:nonNumeric contextRef="From2023-04-28to2023-04-28" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Pursuant to Section 13
or 15(d)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>of the Securities Exchange
Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Date of Report (Date
of earliest event reported): <span id="xdx_909_edei--DocumentPeriodEndDate_c20230428__20230428_z9j279lRFU8"><ix:nonNumeric contextRef="From2023-04-28to2023-04-28" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">April 28, 2023</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_907_edei--EntityRegistrantName_c20230428__20230428_zJ9XhWl325Uj" style="font-size: 14pt"><b><ix:nonNumeric contextRef="From2023-04-28to2023-04-28" name="dei:EntityRegistrantName">CYCLACEL
PHARMACEUTICALS, INC.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Exact name of registrant
as specified in its charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 32%; text-align: center"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20230428__20230428_zLsnsiQJK547" style="font-size: 10pt"><ix:nonNumeric contextRef="From2023-04-28to2023-04-28" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="vertical-align: bottom; width: 2%; text-align: center">&#160;</td>
    <td style="vertical-align: top; width: 32%; text-align: center"><span id="xdx_90D_edei--EntityFileNumber_c20230428__20230428_zGYPEso6io7b" style="font-size: 10pt"><b><ix:nonNumeric contextRef="From2023-04-28to2023-04-28" name="dei:EntityFileNumber">0-50626</ix:nonNumeric></b></span></td>
    <td style="vertical-align: bottom; width: 2%; text-align: center">&#160;</td>
    <td style="vertical-align: top; width: 32%; text-align: center"><span id="xdx_90A_edei--EntityTaxIdentificationNumber_c20230428__20230428_zZdQkPKBao08" style="font-size: 10pt"><b><ix:nonNumeric contextRef="From2023-04-28to2023-04-28" name="dei:EntityTaxIdentificationNumber">91-1707622</ix:nonNumeric></b></span></td></tr>
  <tr>
    <td style="text-align: center; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(State or other jurisdiction</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>of incorporation)</b></p></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>(Commission File Number)</b></span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="text-align: center; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(IRS Employer</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Identification No.)</b></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_908_edei--EntityAddressAddressLine1_c20230428__20230428_ziiJNJj4DLl8"><b><ix:nonNumeric contextRef="From2023-04-28to2023-04-28" name="dei:EntityAddressAddressLine1">200
Connell Drive</ix:nonNumeric></b></span><b>, <span id="xdx_900_edei--EntityAddressAddressLine2_c20230428__20230428_zqERMf4rRhJd"><ix:nonNumeric contextRef="From2023-04-28to2023-04-28" name="dei:EntityAddressAddressLine2">Suite 1500</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_904_edei--EntityAddressCityOrTown_c20230428__20230428_z38oP2Z3Q9Gc"><b><ix:nonNumeric contextRef="From2023-04-28to2023-04-28" name="dei:EntityAddressCityOrTown">Berkeley
Heights</ix:nonNumeric></b></span><b>, <span id="xdx_90C_edei--EntityAddressStateOrProvince_c20230428__20230428_zSIZ00Cn8nnd"><ix:nonNumeric contextRef="From2023-04-28to2023-04-28" name="dei:EntityAddressStateOrProvince">NJ</ix:nonNumeric></span></b><b> <span id="xdx_903_edei--EntityAddressPostalZipCode_c20230428__20230428_zu9mrkskoDf5"><ix:nonNumeric contextRef="From2023-04-28to2023-04-28" name="dei:EntityAddressPostalZipCode">07922</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Address of principal
executive offices and zip code)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Registrant&#8217;s telephone
number, including area code: (<span id="xdx_902_edei--CityAreaCode_c20230428__20230428_zfjKnqEMdtk5"><ix:nonNumeric contextRef="From2023-04-28to2023-04-28" name="dei:CityAreaCode">908</ix:nonNumeric></span></b><b>) <span id="xdx_90C_edei--LocalPhoneNumber_c20230428__20230428_zWl0px6FwwJ7"><ix:nonNumeric contextRef="From2023-04-28to2023-04-28" name="dei:LocalPhoneNumber">517-7330</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Former Name or Former
Address, if Changed Since Last Report)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions (<i>see </i>General Instruction A.2. below): </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_900_edei--WrittenCommunications_c20230428__20230428_zNcYQFNZ1veb" style="font-family: Wingdings"><ix:nonNumeric contextRef="From2023-04-28to2023-04-28" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Written
                                            communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</b></span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.95pt; text-indent: -17.95pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_901_edei--SolicitingMaterial_c20230428__20230428_zsfsvjTijOa7" style="font-family: Wingdings"><ix:nonNumeric contextRef="From2023-04-28to2023-04-28" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Soliciting
                                            material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</b></span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.95pt; text-indent: -17.95pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_905_edei--PreCommencementTenderOffer_c20230428__20230428_zazH5O6H7Mqk" style="font-family: Wingdings"><ix:nonNumeric contextRef="From2023-04-28to2023-04-28" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Pre-commencement
                                            communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</b></span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_909_edei--PreCommencementIssuerTenderOffer_c20230428__20230428_zqd6FPUV38Cc" style="font-family: Wingdings"><ix:nonNumeric contextRef="From2023-04-28to2023-04-28" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Pre-commencement
                                            communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</b></span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">Securities
registered pursuant to Section&#160;12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 24.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 40%"><span style="font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 20%"><span style="font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 40%"><span style="font-size: 10pt"><b>Name of each exchange on which registered
    </b></span></td></tr>
  <tr style="vertical-align: top">
    <td><span id="xdx_906_edei--Security12bTitle_c20230428__20230428__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z4jjN7tgOIFc" style="font-size: 10pt"><ix:nonNumeric contextRef="From2023-04-282023-04-28_us-gaap_CommonStockMember" name="dei:Security12bTitle">Common
    Stock, par value $0.001 per share</ix:nonNumeric></span></td>
    <td><span id="xdx_906_edei--TradingSymbol_c20230428__20230428__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_znygf10RUDxd" style="font-size: 10pt"><ix:nonNumeric contextRef="From2023-04-282023-04-28_us-gaap_CommonStockMember" name="dei:TradingSymbol">CYCC</ix:nonNumeric></span></td>
    <td><span style="font-size: 10pt">The <span id="xdx_908_edei--SecurityExchangeName_c20230428__20230428__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zKeDCMbv9DRb"><ix:nonNumeric contextRef="From2023-04-282023-04-28_us-gaap_CommonStockMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></td></tr>
  <tr style="vertical-align: top">
    <td><span id="xdx_905_edei--Security12bTitle_c20230428__20230428__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_z8ZZsjUihNBj" style="font-size: 10pt"><ix:nonNumeric contextRef="From2023-04-282023-04-28_us-gaap_PreferredStockMember" name="dei:Security12bTitle">Preferred
    Stock, $0.001 par value</ix:nonNumeric></span></td>
    <td><span id="xdx_904_edei--TradingSymbol_c20230428__20230428__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zCWlTqh9aDvg" style="font-size: 10pt"><ix:nonNumeric contextRef="From2023-04-282023-04-28_us-gaap_PreferredStockMember" name="dei:TradingSymbol">CYCCP</ix:nonNumeric></span></td>
    <td><span style="font-size: 10pt">The <span id="xdx_903_edei--SecurityExchangeName_c20230428__20230428__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zwyw1PXmz4Eh"><ix:nonNumeric contextRef="From2023-04-282023-04-28_us-gaap_PreferredStockMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">Emerging
growth company&#160;&#160;<span id="xdx_901_edei--EntityEmergingGrowthCompany_c20230428__20230428_zOIvqxrffDm1" style="font-family: Wingdings"><ix:nonNumeric contextRef="From2023-04-28to2023-04-28" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.75in; text-align: left"><span style="font-size: 10pt"><b>Item 5.02</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 28, 2023, the Board of Directors (the
&#8220;<b>Board</b>&#8221;) of Cyclacel Pharmaceuticals, Inc. (the &#8220;<b>Company</b>&#8221;), after consultation with the Compensation
and Organization Development Committee of the Board of Directors (the &#8220;<b>Committee</b>&#8221;), approved the renewal of the employment
agreements (each, an &#8220;<b>Employment Agreement</b>&#8221;) of Spiro Rombotis, the President and Chief Executive Officer of the Company,
and Paul McBarron, the Executive Vice President - Finance, Chief Financial Officer, Chief Operating Officer and Secretary of the Company,
such renewals to be effective from January 1, 2023 through January 1, 2025. Each of Mr. Rombotis and Mr. McBarron executed his respective
Employment Agreement on April 28, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Employment Agreement for Spiro Rombotis</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to Mr. Rombotis&#8217;
Employment Agreement, Mr. Rombotis&#8217; initial annual base salary is $560,131, which may be increased by the Committee from time to
time, and he may also be eligible for a yearly incentive cash bonus based on a percentage of his then current base salary if he meets
certain corporate and individual performance criteria set by the Committee at the beginning of each year of employment, subject to the
approval of the Board. The Agreement also provides for reimbursement of reasonable and necessary expenses incurred by Mr. Rombotis in
connection with the performance of his services. In addition, Mr. Rombotis is entitled to employment benefits in accordance with the Company&#8217;s
benefit policies in effect from time to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Agreement also provides
for certain severance arrangements for Mr. Rombotis. In the event that Mr. Rombotis&#8217; employment is terminated without &#8220;cause,&#8221;
other than termination for a &#8220;change of control&#8221; (each as defined in the Agreement), the Company will be required to pay Mr.
Rombotis (i) all accrued but unpaid compensation up to the time of such termination; (ii) for a period of twelve months following such
termination, severance payments in the form of continuation of his base salary as in effect immediately prior to such termination, including
coverage of his medical care and life insurance, unless Mr. Rombotis obtains substitute coverage (the &#8220;<b>Severance Payments</b>&#8221;);
and (iii) six months&#8217; accelerated vesting of any options held by Mr. Rombotis. In the event that Mr. Rombotis&#8217; employment
is terminated within six months following a &#8220;change in control&#8221; event, Mr. Rombotis will be entitled to (i) all accrued but
unpaid compensation up to the time of such termination; (ii) Severance Payments for a period of 24 months; (iii) out-of-pocket expenses
reasonably incurred by Mr. Rombotis in connection with his and his family&#8217;s relocation to London; and (iv) 18 months&#8217; accelerated
vesting of any options held by him. In the event of termination due to his death or disability, the Company is required to pay Mr. Rombotis
(or his estate, as the case may be) (i) all accrued but unpaid compensation up to the time of such termination; (ii) Severance Payments
for a period of twelve months; and (iii) he will be entitled to twelve months&#8217; accelerated vesting of his options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, Mr. Rombotis
also agreed to certain confidentiality and assignment of inventions obligations and will be subject to certain non-competition obligations
for a period of one year following termination of his employment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Employment Agreement for Paul McBarron</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to Mr. McBarron&#8217;s
Employment Agreement, Mr. McBarron&#8217;s initial annual base salary is &#163;244,622, which may be increased by the Committee from
time to time, and he may also be eligible for a yearly incentive cash bonus based on a percentage of his then current base salary if he
meets certain corporate and individual performance criteria set by the Committee at the beginning of each year of employment, subject
to the approval of the Board. The Agreement also provides for reimbursement of reasonable and necessary expenses incurred by Mr. McBarron
in connection with the performance of his services. In addition, Mr. McBarron is entitled to employment benefits in accordance with the
Company&#8217;s benefit policies in effect from time to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Agreement also provides
for certain severance arrangements for Mr. McBarron. In the event that Mr. McBarron&#8217;s employment is terminated without &#8220;cause,&#8221;
other than termination for a &#8220;change of control&#8221; (each as defined in the Agreement), the Company will be required to pay Mr.
McBarron (i) all accrued but unpaid compensation up to the time of such termination; (ii) Severance Payments for a period of twelve months
following such termination; and (iii) six months&#8217; accelerated vesting of any options held by Mr. McBarron. In the event that Mr.
McBarron&#8217;s employment is terminated within six months following a &#8220;change in control&#8221; event, Mr. McBarron will be entitled
to (i) all accrued but unpaid compensation up to the time of such termination; (ii) Severance Payments for a period of 12 months; and
(iii) 18 months&#8217; accelerated vesting of any options held by him. In the event of termination due to his death or disability, the
Company is required to pay Mr. McBarron (or his estate, as the case may be) (i) all accrued but unpaid compensation up to the time of
such termination; (ii) Severance Payments for a period of twelve months; and (iii) he will be entitled to twelve months&#8217; accelerated
vesting of his options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, Mr. McBarron
agreed to certain confidentiality and assignment of inventions obligations and will be subject to certain non-competition obligations
for a period of one year following termination of his employment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. McBarron&#8217;s Agreement
also contains certain provisions to assure compliance under the laws of the United Kingdom, Mr. McBarron&#8217;s place of employment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing descriptions
of the Employment Agreements do not purport to be complete and are qualified in their entirety by reference to the forms of Employment
Agreements filed as Exhibits 10.1 and 10.2 to this Current Report on Form 8-K, and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.75in; text-align: left"><span style="font-size: 10pt"><b>Item 9.01</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Financial Statements and Exhibits.</b></span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">(d)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Exhibits.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 9%"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 89%; text-align: center"><span style="font-size: 10pt"><b>Document</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 8.9pt; text-indent: -8.65pt"><a href="tm2314647d1_ex10-1.htm"><span style="font-size: 10pt">10.1</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2314647d1_ex10-1.htm"><span style="font-size: 10pt">Employment Agreement between Cyclacel Pharmaceuticals, Inc. and Spiro
    Rombotis</span></a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 8.9pt; text-indent: -8.65pt"><a href="tm2314647d1_ex10-2.htm"><span style="font-size: 10pt">10.2</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2314647d1_ex10-2.htm"><span style="font-size: 10pt">Employment Agreement between Cyclacel Pharmaceuticals, Inc. and Paul
    McBarron</span></a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 8.9pt; text-indent: -8.65pt">104</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">Cover Page Interactive Data File (embedded with the Inline XBRL document).</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td colspan="2" style="padding: 0; text-indent: 0"><span style="font-size: 10pt"><b>CYCLACEL PHARMACEUTICALS, INC.</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0; width: 5%">&#160;</td>
    <td style="padding: 0; text-indent: 0; width: 45%">&#160;</td>
    <td style="width: 50%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font-size: 10pt">By: </span></td>
    <td style="border-bottom: black 1pt solid; padding: 0; text-indent: 0"><span style="font-size: 10pt">/s/ Paul McBarron</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0; white-space: nowrap; text-indent: 0"><span style="font-size: 10pt">Name: </span></td>
    <td style="padding: 0; text-indent: 0"><span style="font-size: 10pt">Paul McBarron</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0"><span style="font-size: 10pt">Title:</span></td>
    <td style="padding: 0; text-indent: 0"><span style="font-size: 10pt">Executive Vice President-Finance,</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-indent: 0"><span style="font-size: 10pt">Chief Financial Officer and Chief Operating Officer</span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: May 4, 2023</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KgkAQhZ/Adxj2OkylH/IyKYksQiS6XXKKJd2R2dXqkXrLViUaDgwzZ745QkxESltVIcNlnWdQYN1U0iLkeENGfUV3kez2Mbie410Zy1LbYfyBCTkGHTP3V9Lth8tOGSxjCBbTyCmEYBXPlnA6CK/3E9I3VaK2SlYgdQknpoYVWsnv8UMhX6Spfg9JZ2SjSMcQ+sFofyAKwgiO1Mkn8cNAliXCmwzliZSpbfqY1liqYVNh7bLMiP7lfQHn+Ekq -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm2314647d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EMPLOYMENT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>THIS
EMPLOYMENT AGREEMENT</B></FONT> (&ldquo;Agreement&rdquo;) is made as of January&nbsp;1, 2023 by and between Cyclacel Pharmaceuticals,&nbsp;Inc.,
a Delaware corporation, (&ldquo;Company&rdquo;) and Spiro Rombotis (&ldquo;the Executive&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>WHEREAS,
</B></FONT>Company and the Executive are parties to an Employment Agreement dated January&nbsp;1, 2021, which expires by its terms on
January&nbsp;1, 2023; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>WHEREAS</B></FONT>,
Company desires to continue to retain the Executive&rsquo;s services as its President and Chief Executive Officer and the Executive desires
to continue his employment on the terms set forth in this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NOW,
THEREFORE</B></FONT>, in consideration of the foregoing and the mutual covenants and conditions herein contained, the parties hereby agree
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Employment</U></B>.
Company hereby employs the Executive and the Executive accepts such employment according to the terms and conditions set forth in this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Term</U></B>.
Except for earlier termination as hereinafter provided for, the term of the Executive&rsquo;s employment hereunder shall be for a period
commencing on January&nbsp;1, 2023 (&ldquo;Commencement Date&rdquo;) and continuing through January&nbsp;1, 2025; the second anniversary
of the Commencement Date. Notwithstanding the foregoing, the Executive&rsquo;s employment by the Company hereunder may be earlier terminated,
subject to Section&nbsp;9 hereof, upon the occurrence of any one of the following events: (i)&nbsp;the Company&rsquo;s decision to terminate
the Executive, (ii)&nbsp;the Executive&rsquo;s decision to voluntarily resign or retire at any time or (iii)&nbsp;the parties&rsquo; mutual
agreement in writing to terminate the Executive&rsquo;s employment hereunder at any time. The period of time between the Commencement
Date and termination of the Executive&rsquo;s employment hereunder shall be referred to herein as the &ldquo;Employment Period&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Position
and Services.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Executive will hold the position of President and Chief Executive Officer of the Company. The Executive will report directly to the Board
of Directors of the Company (the &ldquo;Board&rdquo;) and shall have such duties, responsibilities and authority with respect to such
positions as are set forth in the Bylaws of the Company, which duties and responsibilities shall in all events include, but not be limited
to, overall management responsibility for the operations and administration of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Executive will be expected to be in the full-time employment of the Company, to devote substantially all of his business time, attention
and efforts to the performance of his duties hereunder. Notwithstanding the foregoing, the Executive may make and manage personal business
investments of his choice and serve in any capacity with any civic, educational or charitable organization, or any trade association,
without seeking or obtaining approval by the Board, provided such activities and service do not materially interfere or conflict with
the performance of his duties hereunder or violate the non-competition provisions of Section&nbsp;12 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Executive expressly agrees that during the Employment Period he will not be interested, directly or indirectly, in any form, fashion or
manner, as a partner, officer, director, advisor, employee, consultant, controlling stockholder or in any other form or capacity, in any
other business or company, except that he would not be prohibited by Section&nbsp;12 hereof to serve as (a)&nbsp;member of one other Board
of Directors of a commercial organization, or (b)&nbsp;a member of one or more Boards of Directors or Trustees of a charitable organization,
as may, upon advance notice from the Executive be approved by the Board in its discretion after consideration of possible conflicts, reputation(al)
effects, time requirements and other interests of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Executive is currently serving as a Class&nbsp;2
director on the Company&rsquo;s Board for a term ending at the 2023 annual meeting. The Board will use its best efforts to cause the nomination
of the Executive thereafter for reelection as Class&nbsp;2 director to the Board for successive terms, at every time at which Class&nbsp;2
directors are nominated to the stockholders for election, as long as the Executive serves as President and Chief Executive Officer unless
the Executive declines such nomination in writing to the Board. As with all members of the Board, the Executive&rsquo;s continuation as
a director requires election as a director by the stockholders whenever directors are to be elected by the stockholders. If the Executive
ceases to serve as President and Chief Executive Officer for any reason and the Board thereafter requests that the Executive resigns as
a director of the Board, the Executive shall immediately resign as a director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Base
Salary</U></B>. Company shall pay to the Executive an initial base salary at an annual rate of $560,131, subject to applicable income
and employment tax withholdings and all other required and authorized payroll deductions and withholdings. The Executive&rsquo;s salary
shall be payable at the same time and basis as the Company pays its payroll in general. Increases in the Executive&rsquo;s annual base
salary during the Employment Period may be effected from time to time based upon the review and approval of the Compensation Committee
of the Board (the &ldquo;Compensation Committee&rdquo;). During the Employment Period, the Executive&rsquo;s base salary rate shall not
be reduced below the initial base salary rate provided hereunder, nor below any increased base salary rate that may be effected as provided
hereunder, except if the Board, in response to exceptionally adverse business circumstances makes a general temporary reduction in the
compensation of the executives of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Annual
Incentive Bonus</U></B>. In addition to the Executive&rsquo;s base salary as provided above, the Executive will be eligible for an annual
cash incentive bonus for each calendar year of the Employment Period. The bonus for which the Executive is eligible for each such year
will be based on a target percentage of the then current base salary, which target percentage shall be at least 50% of Executive&rsquo;s
then current base salary. The determination of the amount of the annual cash incentive bonus will be based upon the satisfaction of performance
criteria established by the Compensation Committee in its discretion and upon consultation with the Executive at the beginning of each
year and subject to the approval of the Board. Depending on the Executives performance against the performance criteria, the actual annual
cash incentive bonus may be more, equal to or less than the target. Such performance criteria will include corporate performance goals
consistent with the Company&rsquo;s business plan for the year, as well as individual objectives for the Executive&rsquo;s performance
that may be separate from, but are consistent with, the Company&rsquo;s business plan. The final determinations as to the actual corporate
and individual performance against the pre-established goals and objectives, and the amount of the bonus payout in relationship to such
performance, will be made by the Compensation Committee in its sole discretion. To the extent the Company awards the Executive a cash
bonus, the bonus, if payable, shall be calculated and paid no later than two and a half months following the later of the close of the
calendar or Company fiscal year to which such bonus relates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Executive
Benefits</U></B>. The Executive shall be entitled to receive employment benefits in accordance with the Company&rsquo;s benefit policies
in effect from time to time, including without limitation, 401(k)&nbsp;plan, medical, dental and life insurance, accidental death, travel
accident, short and long term disability insurance, profit sharing, long term incentive plans, and 15 working days of paid vacation annually.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Expenses</U></B>.
The Company shall reimburse the Executive for all reasonable and necessary expenses incurred by him in connection with the performance
of his services for the Company upon submission of expense reports and documentation in accordance with the Company&rsquo;s policies.
The Company may request additional documentation or a further explanation to substantiate any expense submitted for reimbursement, and
retains the discretion to approve or deny a request for reimbursement. If an expense reimbursement is not exempt from Section&nbsp;409A
of the Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;), any reimbursement in one calendar year shall not affect the
amount that may be reimbursed in any other calendar year and a reimbursement (or right thereto) may not be exchanged or liquidated for
another benefit or payment. Any expense reimbursements subject to Section&nbsp;409A of the Code shall be made no later than the end of
the calendar year following the calendar year in which such business expense is incurred by the Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Indemnification</U></B>.
The Company shall indemnify the Executive in accordance with the Company&rsquo;s By-laws. The Company agrees that it will make all commercially
reasonable efforts to keep in full force and effect, for the duration of all applicable statute of limitations periods, directors and
officers liability insurance policies on terms at least as favorable to the Executive as those in effect on the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Termination</U></B>.
This Agreement does not grant the Executive any right or entitlement to be retained by the Company. In the event of termination by the
Company of the Executive&rsquo;s employment under the circumstances described below in this Section&nbsp;9, the Executive shall be entitled
to the severance pay and benefits so specified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Certain
Definitions</U>. For purposes of this Section&nbsp;9, the following terms shall have the meanings given below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Termination
For Cause</U>. The employment of the Executive hereunder shall be deemed to have been terminated &ldquo;For Cause&rdquo; if the Company
shall have terminated the Executive as a result of any of the following: (A)&nbsp;any act committed by the Executive which shall represent
a breach in any material respect of any of the terms of this Agreement and which breach is not cured within 30 days of receipt by the
Executive of written notice from the Company of such breach; (B)&nbsp;improper conduct, consisting of any willful act or omission with
the intent of obtaining, to the material detriment of the Company, any benefit to which the Executive would not otherwise be entitled;
(C)&nbsp;gross negligence, consisting of wanton and reckless acts or omissions in the performance of the Executive&rsquo;s duties to the
material detriment of the Company; (D)&nbsp;addiction to drugs or chronic alcoholism or (E)&nbsp;any conviction of, or plea of nolo contendere
to, a crime (other than a traffic violation) under the laws of the United States, the United Kingdom, or any of their respective political
subdivisions, provided that the Executive receives a copy of a resolution duly adopted by a two thirds majority affirmative vote of the
membership of the Board excluding the Executive, at a meeting of the Board called and held for such purpose after the Executive has been
given reasonable notice of such meeting and has been given an opportunity, together with his counsel, to be heard by the Board, finding
that in the good faith opinion of the Board the Executive was guilty of the conduct set forth and specifying the particulars thereof in
detail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Termination
Without Cause.</U> The employment of the Executive hereunder shall be deemed to have been terminated &ldquo;Without Cause&rdquo; upon
(A)&nbsp;termination of employment by the Company for any reason other than the reasons specified in <U>Section&nbsp;9(a)(i)</U>&nbsp;hereof
as termination &ldquo;For Cause&rdquo; or the reasons specified in <U>Section&nbsp;9(a)(iii)</U>&nbsp;hereof as termination because of
the Executive&rsquo;s Disability or Death, (B)&nbsp;termination of employment by the Company by virtue of the expiry of the Employment
Period on 1 January&nbsp;2025 (or any specific extension thereof), unless the Company has offered in writing to renew the Executive&rsquo;s
employment after the expiry of the Employment Period on terms no less favorable than those provided in this Agreement (in which case if
the Executive does not accept renewal of his employment, the termination of his employment by virtue of the expiry of the Employment Term
will be deemed a resignation by the Executive), or (C)&nbsp;termination of employment by the Executive within 30 days following a &ldquo;Constructive
Termination&rdquo; event. For purposes hereof, the following shall constitute Constructive Termination events: (1)&nbsp;any removal of
the Executive from the position of President or Chief Executive Officer, (2)&nbsp;any material reduction of the Executive&rsquo;s duties,
responsibilities or authority, including any change in the Executive&rsquo;s positions as President or Chief Executive Officer that results
in such a reduction, (3)&nbsp;a material reduction by the Company in the Executive&rsquo;s base salary in effect on the date hereof or
as may be increased from time to time except if the Board in response to exceptional adverse business circumstances makes a general temporary
reduction in the compensation of the executives of the Company, (4)&nbsp;the Company requiring the Executive without the Executive&rsquo;s
express written consent to be based anywhere other than within 50 miles of a Company office existing as of the date of this Agreement,
unless the Executive would be based closer to his primary residence and except for required travel on the Company&rsquo;s business to
an extent substantially consistent with the Executive&rsquo;s present business travel obligations, or (5)&nbsp;a material breach of this
Agreement by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing shall be treated as Constructive
Termination events hereunder following the expiration of 30 days from the date the Executive has notified Company (within 90 days) of
the occurrence of such event and the Executive&rsquo;s intention to treat such event as a constructive termination and terminate the Executive&rsquo;s
employment on the basis thereof, provided that Company has not cured the constructive termination event before the expiration of such
30-day period. The Executive&rsquo;s termination will be effective upon the expiration of the 30-day period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Disability.</U>
The Executive shall be treated as having suffered a &ldquo;Disability&rdquo; if the Executive is prevented from performing his duties
hereunder by reason of illness or injury for a period of either (A)&nbsp;six or more consecutive months from the First Date of Disability
(as defined below) or (B)&nbsp;eight months in the aggregate during any 12-month period. The date as of which the Executive is first absent
from employment as a result of such illness or injury shall be referred to herein as the &ldquo;First Date of Disability&rdquo;. Notwithstanding
the foregoing, if and only to the extent that Executive&rsquo;s disability is a trigger for the payment of deferred compensation, as defined
in Section&nbsp;409A of the Code, &ldquo;disability&rdquo; shall have the meaning set forth in Section&nbsp;409A(a)(2)(C)&nbsp;of the
Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Change
in Control</U>. A &ldquo;Change in Control&rdquo; shall be deemed to have taken place if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(A)&nbsp; there shall be consummated
any consolidation or merger of the Company in which Company is not the continuing or surviving corporation or pursuant to any transaction
in which shares of the Company&rsquo;s capital stock are converted into cash, securities or other property, or any sale, lease, exchange
or other transfer in one transaction or a series of transactions contemplated or arranged by any party as a single plan of all or substantially
all of the assets of the Company, or the approval of a plan of complete liquidation or dissolution of the Company adopted by the stockholders
of the Company; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(B)&nbsp; any person (as such
term is used in Sections 13(d)&nbsp;and 14(d)(2)&nbsp;of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;))
shall after the date hereof become the beneficial owner (as defined in Rules&nbsp;13d-3 and 13d-5 under the Exchange Act), directly or
indirectly, of securities of the Company representing 35% or more of the voting power of all then outstanding securities of the Company
having the right under ordinary circumstances to vote in an election of the Board (including, without limitation, any securities of the
Company that any such person has the right to acquire pursuant to any agreement, or upon exercise of conversion rights, warrants or options,
or otherwise, shall be deemed beneficially owned by such person); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(C)&nbsp; individuals who at
the date hereof constitute the entire Board and any new directors whose election by the Board, or whose nomination for election by the
Company&rsquo;s stockholders, shall have been approved by a vote of at least a majority of the directors then in office who either were
directors at the date hereof or whose election or nomination for election shall have been so approved (the &ldquo;Continuing Directors&rdquo;)
shall cease for any reason to constitute a majority of the members of the Board; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>provided
further</U></FONT> that in each of the foregoing cases, the Change of Control also meets all of the requirements of a &ldquo;change in
the ownership of a corporation&rdquo; within the meaning of Treasury Regulation &sect;1.409A-3(i)(5)(v), a &ldquo;change in the effective
control of a corporation&rdquo; within the meaning of Treasury Regulation &sect;1.409A-3(i)(5)(vi)&nbsp;or a &ldquo;a change in the ownership
of a substantial portion of the corporation&rsquo;s assets&rdquo; within in the meaning of Treasury Regulation &sect;1.409A-3(i)(5)(vii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Termination
Without Cause</U>. In the event of termination of the Executive&rsquo;s employment hereunder by Company &ldquo;Without Cause&rdquo; (other
than for a Termination for a Change of Control hereinafter separately provided for) the Executive shall be entitled to the following severance
pay and benefits:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Severance
Pay </I>- severance payments in the form of continuation of the Executive&rsquo;s base salary as in effect immediately prior to such termination
for a period of 12 months commencing on the sixtieth (60<SUP>th</SUP>) day following the effective date of such termination;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Benefits
Continuation</I> &ndash; continued coverage under the Company&rsquo;s medical care and life insurance benefit plans in which the Executive
is participating at the time of termination, or equivalent coverage thereof, on the same terms as applicable to other executive employees
of the Company from time to time, over the same period with respect to which the Executive&rsquo;s base salary is continued as provided
in Section&nbsp;9(b)(i)&nbsp;hereof; provided, however, that the Company&rsquo;s obligation to provide such coverages shall be terminated
if the Executive obtains substitute coverage from another employer of the Executive at any time during the continuation period; the Executive
shall be obligated to notify Company of any such substitute coverage and the date of commencement thereof promptly upon obtaining any
such coverage. The Executive shall be entitled, at the expiration of the period of benefits continuation under this Section&nbsp;9(b)(ii),
to elect continued medical coverage upon timely election of COBRA continuation coverage, in accordance with Section&nbsp;4980B of the
Internal Revenue Code of 1986, as amended (or any successor provision thereto) with the Company premiums paid at the same percentage as
prior to the Executive&rsquo;s termination; provided that, if COBRA continuation coverage is otherwise earlier terminated under applicable
law, then, in lieu of coverage, the Company will pay its share of the monthly Company premium in effect prior to the termination of COBRA
continuation coverage directly to the Executive each month for the remainder of the relevant period. Any amounts paid by the Company on
Executive&rsquo;s behalf under this Section&nbsp;9(b)(ii)&nbsp;to continue the Executive&rsquo;s medical care and life insurance benefits
shall be recorded as additional income pursuant to Section&nbsp;6041 of the Code and shall not be entitled to any tax qualified treatment;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Stock
Options</I> - all options to purchase shares of the Company&rsquo;s common stock held by the Executive and which are vested immediately
prior to termination of employment shall become exercisable for a period of six months following the effective date of termination of
employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Termination
following Change in Control</U>. In the event of termination of the Executive&rsquo;s employment within six months following a Change
of Control the Executive shall be entitled to the following severance pay and benefits:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Severance
Pay </I>-Severance payments in the form of continuation as the Executive&rsquo;s base salary as in effect immediately prior to such termination
for a period of 24 months commencing on the sixtieth (60<SUP>th</SUP>) day following the effective date of termination;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Benefits
Continuation</I> - Provided that Executive timely elects continued medical coverage under COBRA in accordance with Section&nbsp;4980B
of the Internal Revenue Code of 1986, as amended (or any successor provision thereto), the Company will continue to pay the premiums paid
at the same percentage as prior to the Executive&rsquo;s termination for the lesser of 18 months and the date Executive obtains substitute
coverage from another employer; Executive shall be obligated to notify Company of any such substitute coverage and the date of commencement
thereof promptly upon obtaining any such coverage; during the period the Company continues to pay premiums, the Company will treat the
reimbursement of the monthly premiums as pre-tax contributions to the Company&rsquo;s health plan on Executive&rsquo;s behalf, provided
that if the reimbursement of any COBRA premiums would violate the nondiscrimination rules&nbsp;or cause the reimbursement to be taxable
under the Patient Protection and Affordable Care Act of 2010, the Health Care and Education Reconciliation Act of 2010 (collectively,
the &ldquo;<U>Act</U>&rdquo;) or Section&nbsp;105(h)&nbsp;of the Internal Revenue Code, the premiums will be treated as taxable payments
and be subject to imputed income tax treatment to the extent necessary to eliminate any discriminatory treatment or taxation under the
Act or Section&nbsp;105(h)&nbsp;of the Code; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Stock
Options</I> - all options to purchase shares of the Company&rsquo;s common stock held by the Executive shall be vested and be exercisable
for a period of 18 months following the effective date of termination; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Return
to London</I> - the Company will reimburse Executive for out of pocket expenses reasonably incurred by the Executive, subject to an aggregate
cap of $15,000, in connection with the relocation of Executive&rsquo;s family and household goods from the New York-New Jersey metropolitan
area to London, provided, however, that (i)&nbsp;the Executive actually relocates his family and household goods within one year following
the date the termination of his employment becomes effective; and (ii)&nbsp;all such expenses are reimbursed on or before the last day
of the second taxable year following the year in which the Executive&rsquo;s employment terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>280G
Excise Tax</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;It
is the intention of Executive and the Company that no payments made or benefits provided by the Company to or for the benefit of Executive
under this Agreement or any other agreement or plan pursuant to which Executive is entitled to receive payments or benefits shall be subject
to the excise tax imposed on the Executive by Section&nbsp;4999 of the Code (the &ldquo;280G Excise Tax&rdquo;), relating to golden parachute
payments. The Company agrees that in the event any payments to Executive pursuant to this Agreement would result in a payment to Executive
that would trigger any 280G Excise Tax, if appropriate and permissible, the Company shall first submit to its stockholders for approval
the transaction that may result in the imposition of the 280G Excise Tax upon Executive in accordance with the regulations of the Internal
Revenue Code governing shareholder approval of transactions giving rise to 280G Excise Tax liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the Company is unable to submit to its stockholders for approval the transaction that may result in the imposition of the 280G Excise
Tax and to the extent that any payment, benefit or distribution of any type to or for the benefit of the Executive by the Company or any
of its affiliates, whether paid or payable, provided or to be provided, or distributed or distributable pursuant to the terms of this
Agreement or otherwise (including, without limitation, any accelerated vesting of stock options or other equity-based awards) (collectively,
the &ldquo;<U>Total Payments</U>&rdquo;) would be subject to the 280G Excise Tax, then the Total Payments shall be reduced (but not below
zero) so that the maximum amount of the Total Payments (after reduction) shall be one dollar ($1.00) less than the amount which would
cause the Total Payments to be subject to the 280G Excise Tax, but only if the Total Payments so reduced result in the Executive receiving
a net after tax amount that exceeds the net after tax amount the Executive would receive if the Total Payments were not reduced and were
instead subject to the 280G Excise Tax. If a reduction is required, the Company shall reduce or eliminate the Total Payments by first
reducing or eliminating any cash severance benefits (with the payments to be made furthest in the future being reduced first), then by
reducing or eliminating any accelerated vesting of stock options or similar awards, then by reducing or eliminating any accelerated vesting
of restricted stock or similar awards, then by reducing or eliminating any other remaining Total Payments. The preceding provisions of
this Section&nbsp;shall take precedence over the provisions of any other plan, arrangement or agreement governing the Executive&rsquo;s
rights and entitlements to any benefits or compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Termination
Upon Disability or Death</U>. In the event of termination of the Executive&rsquo;s employment hereunder on account of the Executive&rsquo;s
 &ldquo;Disability&rdquo; or death, the Executive or the Executive&rsquo;s heirs, estate or personal representatives under law, as applicable,
shall be entitled to the following severance pay and benefits:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Severance
Pay</I> - severance payments in the form of continuation of the Executive&rsquo;s base salary as in effect immediately prior to such termination
for a period of 12 months commencing on the sixtieth (60<SUP>th</SUP>) day following the effective date of the termination, reduced by
any amounts paid to the Executive in the time period following the First Date of Disability and until the date of termination, and any
payments received from any short-term or long-term disability plan of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Benefits
Continuation</I> - the same benefits as provided in Section&nbsp;9(c)(ii)&nbsp;above, to be provided during the Employment Period while
the Executive is suffering from Disability and for a period of 12 months following the effective date of termination of employment by
reason of Disability; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><I>Stock
Options</I> - all options to purchase shares of the Company&rsquo;s common stock held by the Executive which are exercisable immediately
prior to termination of employment shall remain exercisable for a period of 12 months following the effective date of termination of employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Other
Terminations</U>. In the event of termination of the Executive&rsquo;s employment hereunder for any reason other than those specified
in subsections (b)&nbsp;through (d)&nbsp;of this Section&nbsp;9, the Executive shall not be entitled to any severance pay, benefits continuation
or stock option rights contemplated by the foregoing provisions of this Section&nbsp;9, except as otherwise provided in the applicable
benefit plans of the Company that cover the Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Accrued
Rights</U>. Notwithstanding the foregoing provisions of this Section&nbsp;9, in the event of termination of the Executive&rsquo;s employment
hereunder for any reason, the Executive shall be entitled to payment of any unpaid portion of his base salary, computed on a pro-rata
basis through the effective date of termination, and payment of any accrued but unpaid rights in accordance with the terms of any incentive
bonus or employee benefit plan or program of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Conditions
to Severance Benefits</U>. (i)&nbsp;As conditions of the Executive&rsquo;s entitlement and continued entitlement to the severance payments
and benefits provided by this Section&nbsp;9, the Executive is required to (i)&nbsp;honor in accordance with their terms the provisions
of Sections 10, 11 and 12 hereof and (ii)&nbsp;execute and honor the terms of a waiver and release of claims against the Company substantially
in the form attached hereto as Exhibit&nbsp;A (and as may be modified consistent with the purposes of such waiver and release to reflect
changes in law following the date hereof), which must be effective and irrevocable prior to the sixtieth (60<SUP>th</SUP>) day following
the effective date of the termination of the Executive&rsquo;s employment. The parties hereto agree that the Executive is under no affirmative
obligation to seek to mitigate or offset the severance payments and benefits provided by this Section&nbsp;9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
purposes only of this Section, the Executive shall be treated as having failed to honor the provisions of Sections 10, 11 or 12 hereof
only upon the passing of a resolution by a majority of the Board making such a determination following notice of the alleged failure by
Company to the Executive, an opportunity for the Executive to cure the alleged failure for a period of 30 days from the date of such notice
and the Executive&rsquo;s opportunity to be heard on the issue by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock
Options</U>. </FONT>Notwithstanding any other provisions of this Agreement to the contrary, in the event that the Executive continues
to serve as a member of the Board following his termination of employment from the Company, his rights with respect to vesting and exercisability
of his then outstanding options shall continue under the same terms and conditions as if the Executive had not terminated employment until
such time as the Executive is no longer providing services to the Company as a non-executive member of the Board. In addition, any option
which is deemed to be an Incentive Stock Option pursuant to Section&nbsp;422 of the Code, shall become a Nonqualified Stock Option on
the date that is three months after termination of Executive&rsquo;s employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Confidentiality</U></B>.
The Executive agrees that he will not at any time during the term hereof or thereafter for any reason, in any fashion, form or manner,
either directly or indirectly, divulge, disclose or communicate to any person, firm, corporation or other business entity, in any manner
whatsoever, any confidential information or trade secrets concerning the business of the Company (including the business of any unit thereof),
including, without limiting the generality of the foregoing, the names of any of its customers, the prices at which it obtains or has
obtained any products or services, the techniques, methods or systems of its operation or management, any customer proposals or other
business opportunities, any information regarding its financial matters, or any other material information concerning the business of
the Company, its manner of operation, its plans or other material data. The provisions of this paragraph shall not apply to (i)&nbsp;information
disclosed in the performance of the Executive&rsquo;s duties to the Company based on his good faith belief that such a disclosure is in
the best interests of the Company; (ii)&nbsp;information that is public knowledge; (iii)&nbsp;information disseminated by the Company
to others in the ordinary course of the Company&rsquo;s business, in order to further such business, provided the recipient of such information
agrees to be subject to a confidentiality obligation at least comparable to that herein; (iv)&nbsp;information or knowledge lawfully received
by the Executive from a third party who, based upon due inquiry by the Executive, is not bound by a confidential relationship to the Company;
or (v)&nbsp;information disclosed under a requirement of law or as directed by applicable legal authority having jurisdiction over the
Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Inventions</U></B>.
(i)&nbsp;To the extent that any of the Company&rsquo;s current or future products or services relate to, embody or incorporate concepts,
technology or products of any kind relevant to the Company or its subsidiaries or affiliates that the Executive directly or indirectly
conceived or developed prior to the date hereof during the period of his employment by Company (&ldquo;Prior Technology&rdquo;), the Executive
assigns in perpetuity to Company any and all of his rights, title and interests, if any, to utilize, without any cost to the Company,
such Prior Technology, and the Executive agrees to assist Company in taking all action that may be reasonably required, at the Company&rsquo;s
expense, to secure for the Company the benefits of the Executive&rsquo;s ownership or rights, if any, to use all such Prior Technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii)&nbsp;The Executive is
hereby retained in a capacity such that the Executive&rsquo;s responsibilities include the making of technical, managerial and promotional
contributions of value to the Company. The Executive hereby assigns to Company all rights, title and interest in such contributions and
inventions made or conceived by the Executive alone or jointly with others which relate to the business of the Company. This assignment
shall include (a)&nbsp;the right to file and prosecute patent applications on such inventions in any and all countries, (b)&nbsp;the patent
applications filed and patents issuing thereon, and (c)&nbsp;the right to obtain copyright, trademark or trade name protection for any
such work product. The Executive shall promptly and fully disclose all such contributions and inventions to the Company and assist the
Company in obtaining and protecting the rights therein (including patents thereon), in any and all countries; provided, however, that
said contributions and inventions will be the property of the Company, whether or not patented or registered for copyright, trademark
or trade name protection, as the case may be. Inventions conceived by the Executive which are not related to the business of the Company
(as determined in good faith by the Board), will remain the property of the Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Non-Competition</U></B>.
(i)&nbsp; the Executive agrees that he shall not during the Employment Period and for a period of one year after the termination or end
thereof for any reason, without the approval of the Board which, after the end of the Employment Period, shall not unreasonably be withheld
or delayed, directly or indirectly, alone or as partner, joint venturer, officer, director, employee, consultant, agent, independent contractor
or controlling stockholder (other than as provided below) of any Company or business, engage in any &ldquo;Competitive Business&rdquo;
within the United States and within the United Kingdom. For purposes of the foregoing, the term &ldquo;Competitive Business&rdquo; shall
mean any business involved in and/or intending to seek marketing approvals of drug candidates belonging to the same pharmaceutical class
as the candidates under development by the Company from time to time, currently CDK inhibitors, PLK inhibitors and nucleoside analogues;
provided that, this provision shall in no way prevent the Executive, after the end of the Employment Period, from being employed as a
consultant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii)&nbsp; Notwithstanding
the provisions of clause (i)&nbsp;above or any other provision of this Agreement to the contrary, the Executive shall not be prohibited
during the period applicable under clause (i)&nbsp;above from acting as a passive investor where (a)&nbsp;in the case of a Competitive
Business being a public corporation, the Executive owns not more than five percent (5%) of the issued and outstanding capital stock or
such higher percentage or amount as may be approved by the Board upon notice from the Executive prior to obtaining such interest; provided,
however, that the Executive shall not be treated as having violated the provisions of this Section&nbsp;12 if in good faith he is unaware
that an entity in which he has an investment interest would be treated as a Competitive Business and, upon becoming aware of such involvement,
the Executive makes reasonable efforts to divest himself of his interest in such business; (b)&nbsp;in the case of any employer or entity
other than a Competitive Business that is engaged in, or whose affiliates are engaged in, the development or marketing of products or
technologies that are directly or indirectly competitive with any product or technology that is developed or marketed or proposed to be
developed or marketed by Company during the Employment Period, the Executive owns not more than five percent (5%) of the issued and outstanding
capital stock; or (c)&nbsp;receiving stock, options or warrants from any entity with which the Executive can have a relationship pursuant
to clause (i)&nbsp;above as part of the Executive&rsquo;s compensation for services rendered or to be rendered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Breach
of Restrictive Covenants.</U></B> The parties agree that a breach or violation of Sections 10, 11 or 12 hereof will result in immediate
and irreparable injury and harm to the innocent party, who shall have, in addition to any and all remedies of law and other consequences
under this Agreement, the right to an injunction, specific performance or other equitable relief to prevent the violation of the obligations
hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><B><U>Non-Disparagement</U></B>.
The Executive agrees that he will not, whether during his provision of services to the Company or thereafter, directly or indirectly,
make, cause to be made, or ratify any statement, public or private, oral or written, to any person that disparages, either professionally
or personally, the Company or any of its affiliates, past and present, and each of them, as well as its and their trustees, directors,
officers, agents, attorneys, insurers, employees, stockholders, representatives, assigns, and successors, past and present, and each of
them</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Whistleblower;
Defend Trade Secrets Act</U></B>. Nothing in this Agreement shall prohibit the Executive from reporting possible violations of federal
law or regulation to any governmental agency or entity including but not limited to the Department of Justice, the Securities and Exchange
Commission, the Equal Employment Opportunity Commission, and any Inspector General, or making other disclosures that are protected under
the whistleblower provisions of federal law or regulation. The Executive does not need the prior authorization of the Company to make
any such reports or disclosures and the Executive is not required to notify the Company that the Executive has made such reports or disclosures.
Under the Defend Trade Secrets Act of 2016, the Company hereby provides notice and Executive hereby acknowledges that Executive may not
be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i)&nbsp;is
made (A)&nbsp;in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney and (B)&nbsp;is
solely for the purpose of reporting or investigating a suspected violation of law; or (ii)&nbsp;is made in a complaint or other document
filed in a lawsuit or other proceeding, if such filing is made under seal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Notices</U></B>.
Any notice required to be given pursuant to the provisions of this Agreement shall be in writing and, if mailed, sent by registered mail,
postage prepaid, to the party named at the address set forth below, or at such other address as each party may hereafter designate in
writing to the other party:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 1in; text-align: left">Company:</TD><TD STYLE="text-align: justify">200 Connell Drive #1500</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">Berkeley Heights, NJ 07922</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">Attention: Chairman of the Board</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify">with a copy to (which copy will not constitute
notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 1in">Mintz Levin Cohn Ferris
Glovsky&nbsp;&amp; Popeo, P.C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 1in">919
Third Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 1in">New
York, New York 10022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 1in">Attention:
Joel Papernik,&nbsp;Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 1in; text-align: left">Executive:</TD><TD STYLE="text-align: justify">c/o Cyclacel Pharmaceuticals,&nbsp;Inc.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 1in">200 Connell Drive #1500</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: 1in">Berkeley Heights, NJ
07922</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any such notices shall be deemed to have been
delivered when served personally in the manner specified above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Dispute
Resolution</U></B>. The parties shall waive trial by jury in any dispute between them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Entire
Agreement</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Change,
Modification, Waiver</U>. No change or modification of this Agreement shall be valid unless it is in writing and signed by each of the
parties hereto. No waiver of any provision of this Agreement shall be valid unless it is in writing and signed by the party against whom
the waiver is sought to be enforced. The failure of a party to insist upon strict performance of any provision of this Agreement in any
one or more instances shall not be construed as a waiver or relinquishment of the right to insist upon strict compliance with such provision
in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Integration
of All Agreements</U>. This Agreement constitutes the entire Agreement between the parties and is intended to be an integration of all
agreements between the parties with respect to the Executive&rsquo;s service with Company. Except as provided in Section&nbsp;8 hereof
concerning the Indemnification Agreement, any and all prior agreements between the Executive and the Company with respect to the Executive&rsquo;s
service with the Company are hereby revoked.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Severability
of Provisions</U>. If for any reason any provision of this Agreement should be declared void or invalid, such declaration shall not affect
the validity of the rest of this Agreement, which shall remain in force as if executed with the void or invalid provision eliminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Binding
Effect</U></B>. This Agreement shall be binding upon all parties hereto and their heirs, successors and assigns. This Agreement shall
be assignable by Company to any entity acquiring all or substantially all of the assets of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Governing
Law</U></B>. This Agreement shall be governed by and construed in accordance with the laws of the State of New Jersey.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Miscellaneous.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Form</U>.
As employed in this Agreement, the singular form shall include, if appropriate, the plural.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Headings</U>.
The headings employed in this Agreement are solely for the convenience and reference of the parties and are not intended to be descriptive
of the entire contents of any paragraph and shall not limit or otherwise affect any of terms, provisions, or construction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Compliance
with Section&nbsp;409A of the Code</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>To
the extent any of the benefits payable under Section&nbsp;9(b), (c)&nbsp;or (d)&nbsp;of this Agreement constitute non-qualified deferred
compensation subject to Section&nbsp;409A of the Code, the following provisions shall apply:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Any
termination of employment triggering payment of such benefits must constitute a &ldquo;separation from service&rdquo; under Section&nbsp;409A
of the Code before distribution of such benefits can commence. For purposes of clarification, this paragraph shall not cause any forfeiture
of benefits on the part of the Executive, but shall only act as a delay until such time as a &ldquo;separation from service&rdquo; occurs.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If
the Executive is a &ldquo;specified employee&rdquo; (as that term is used in Section&nbsp;409A of the Code and regulations and other guidance
issued thereunder) on the date his separation from service becomes effective, any benefits payable under Section&nbsp;9 that constitute
non-qualified deferred compensation subject to Section&nbsp;409A of the Code shall be delayed until the earlier of (A)&nbsp;the business
day following the six-month anniversary of the date his separation from service becomes effective, and (B)&nbsp;the date of the Employee&rsquo;s
death, but only to the extent necessary to avoid the imposition of accelerated or increased income taxes, excise taxes or other penalties
under Section&nbsp;409A of the Code. On the earlier of (A)&nbsp;the business day following the six-month anniversary of the date his separation
from service becomes effective, and (B)&nbsp;the Executive&rsquo;s death, the Company shall pay the Executive in a lump sum the aggregate
value of the non-qualified deferred compensation that the Company otherwise would have paid the Executive prior to that date under Section&nbsp;9
of this Agreement.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>It
is intended that each installment of the payments and benefits provided under Section&nbsp;9 this Agreement shall be treated as a separate
 &ldquo;payment&rdquo; for purposes of Section&nbsp;409A of the Code. In particular, if the installment severance payments set forth in
Sections 9(b)(i), 9(c)(i)&nbsp;and 9(d)(i)&nbsp;of this Agreement otherwise qualify under Treas. Reg. &sect;1.409A-1(b)(9)(iii)&nbsp;as
an involuntary separation plan, the installment severance payments shall be divided into two portions. That number of installments commencing
on the first payment date set forth in Sections 9(b)(i), 9(c)(i)&nbsp;and 9(d)(i)&nbsp;of this Agreement that are in the aggregate less
than two times the applicable compensation limit under Section&nbsp;401(a)(17) of the Code for the year in which the termination of the
Executive&rsquo;s employment occurs (provided the termination of the Executive&rsquo;s employment is also a &ldquo;separation from service&rdquo;)
shall be payable in accordance with Treas. Reg. &sect;1.409A-1(b)(9)(iii)&nbsp;as an involuntary separation plan. The remainder of the
installments shall be paid in accordance with Sections 21(a)(i)&nbsp;and (ii)&nbsp;above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Neither
the Company nor Executive shall have the right to accelerate or defer the delivery of any such payments or benefits except to the extent
specifically permitted or required by Section&nbsp;409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Notwithstanding
any other provision of this Agreement to the contrary, if any term in the Agreement is ambiguous, such term or terms shall be interpreted
in a manner that avoids the inclusion of compensation in income under Section&nbsp;409A(a)(1)&nbsp;of the Code. For purposes of clarification,
this Section&nbsp;20 shall be a rule&nbsp;of construction and interpretation and nothing in this Section&nbsp;20 shall cause a forfeiture
of benefits on the part of the Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[signature page&nbsp;follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>IN
WITNESS WHEREOF</B></FONT>, this Agreement is executed as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left"><FONT STYLE="font-size: 10pt">Cyclacel Pharmaceuticals,&nbsp;Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt"><U>/s/
    Paul McBarron</U></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt"><U>Paul
    McBarron</U></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt"><U>Executive
    Vice President-Finance, Chief Financial Officer and Chief Operating Officer</U></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left"><FONT STYLE="font-size: 10pt">Spiro Rombotis</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">/s/
    Spiro Rombotis</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">EXHIBIT&nbsp;A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Waiver and Release</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><U>Your
Release of Claims.</U></B> You hereby agree and acknowledge that by signing this Agreement, and for other good and valuable consideration,
you are waiving your right to assert any and all forms of legal claims against the Company<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>1</SUP></FONT><SUP>/</SUP>
of any kind whatsoever, whether known or unknown, arising from the beginning of time through the date you execute this Agreement (the
 &ldquo;Execution Date&rdquo;). Except as set forth below, your waiver and release herein is intended to bar any form of legal claim, complaint
or any other form of action (jointly referred to as &ldquo;Claims&rdquo;) against the Company seeking any form of relief including, without
limitation, equitable relief (whether declaratory, injunctive or otherwise), the recovery of any damages, or any other form of monetary
recovery whatsoever (including, without limitation, back pay, front pay, compensatory damages, emotional distress damages, punitive damages,
attorneys&rsquo; fees and any other costs) against the Company, for any alleged action, inaction or circumstance existing or arising through
the Execution Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Without limiting the foregoing
general waiver and release, you specifically waive and release the Company from any Claim arising from or related to your prior employment
relationship with the Company or the termination thereof, including, without limitation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">**</TD><TD STYLE="text-align: justify">Claims under any state or federal discrimination, fair employment practices or other employment related
statute, regulation or executive order (as they may have been amended through the Execution Date) prohibiting discrimination or harassment
based upon any protected status including, without limitation, race, national origin, age, gender, marital status, disability, veteran
status or sexual orientation. Without limitation, specifically included in this paragraph are any Claims arising under the Age Discrimination
in Employment Act, Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Americans With Disabilities Act and any
similar Federal and state statute.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">**</TD><TD STYLE="text-align: justify">Claims under any other state or federal employment related statute, regulation or executive order (as
they may have been amended through the Execution Date) relating to wages, hours or any other terms and conditions of employment.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">**</TD><TD STYLE="text-align: justify">Claims under any state or federal common law theory including, without limitation, wrongful discharge,
breach of express or implied contract, promissory estoppel, unjust enrichment, breach of a covenant of good faith and fair dealing, violation
of public policy, defamation, interference with contractual relations, intentional or negligent infliction of emotional distress, invasion
of privacy, misrepresentation, deceit, fraud or negligence.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><SUP>1/</SUP></TD><TD STYLE="text-align: justify">For purposes of this Agreement, the Company includes the Company
and any of its divisions, affiliates (which means all persons and entities directly or indirectly controlling, controlled by or under
common control with the Company), subsidiaries and all other related entities, and its and their directors, officers, employees, trustees,
agents, successors and assigns.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">**</TD><TD STYLE="text-align: justify">Any other Claim arising under state or federal law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Notwithstanding
the foregoing, nothing contained in this Release constitutes a waiver of </FONT>any Claims you may have against the Company arising from
or related to the Indemnification Agreement and By-laws provisions referenced in Section&nbsp;8 of the Employment Agreement, dated January&nbsp;1,
2014, entered into between you and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You acknowledge and agree
that, but for providing this waiver and release, you would not be receiving the economic benefits being provided to you under the terms
of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>It is the Company&rsquo;s
desire and intent to make certain that you fully understand the provisions and effects of this Agreement. To that end, you have been encouraged
and given the opportunity to consult with legal counsel for the purpose of reviewing the terms of this Agreement. Also, because you are
over the age of 40 and consistent with the provisions of the Age Discrimination in Employment Act (&ldquo;ADEA&rdquo;), which prohibits
discrimination on the basis of age, the Company is providing you with twenty-one (21) days in which to consider and accept the terms of
this Agreement by signing below and returning it to me at: [name], [address].</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>You may rescind your assent
to this Agreement if, within seven (7)&nbsp;days after you sign this Agreement, you deliver by hand or send by mail (certified, return
receipt and postmarked within such 7 day period) a notice of rescission to me at the Company. The eighth day following your signing of
this Agreement is the Effective Date.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Also, nothing in this Agreement:
(i)&nbsp;prohibits or restricts you from filing a charge or complaint against the Company with any federal, state or local government
authority, including a charge of unlawful discrimination with the Equal Employment Opportunity Commission or a state or local government
authority responsible for enforcing laws prohibiting discriminatory employment practices; (ii)&nbsp;prohibits or restricts you from communicating
with, providing relevant information to or otherwise cooperating with any government authority, including the EEOC or a state or local
government authority responsible for enforcing laws prohibiting discriminatory employment practices, including without limitation, responding
to any inquiry from such government authority, including an inquiry about the existence of this Agreement or its underlying facts; or
(iii)&nbsp;requires you to notify the Company of your communications with or inquiries from any government authority. To the maximum extent
permitted by law, however, you are not entitled to recover any legal or equitable remedies, including reinstatement or monetary damages,
in the case of any administrative claim that he files or in which he participates, except as set forth herein and except that he retains
the right to receive an award for actionable information he provides to a government authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 46%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Spiro Rombotis</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%">Date signed:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 41%">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>tm2314647d1_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>EMPLOYMENT
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>THIS
EMPLOYMENT AGREEMENT</B></FONT> (the &ldquo;Agreement&rdquo;) is made as of January&nbsp;1, 2023 by and between Cyclacel Pharmaceuticals,&nbsp;Inc.
(the &ldquo;Company&rdquo;), a Delaware corporation, and Paul McBarron (the &ldquo;Executive&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>WHEREAS,
</B></FONT>Company and Executive are parties to an Employment Agreement dated January&nbsp;1, 2021, which expires by its terms on January&nbsp;1,
2023; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>WHEREAS,</B></FONT>
Company desires to continue to retain the Executive&rsquo;s services as its <FONT STYLE="background-color: white">Executive Vice President,
Finance, Chief Financial Officer, Chief Operating Officer and Secretary and the Executive desires to continue his employment on the terms
set forth in this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NOW,
THEREFORE,</B></FONT> in consideration of the foregoing and the mutual covenants and conditions herein contained, the parties hereby agree
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Employment</U>.</B>
Company hereby employs the Executive and the Executive accepts such employment according to the terms and conditions set forth in this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Term</U>.</B>
Except for earlier termination as hereinafter provided for, the term of the Executive&rsquo;s employment hereunder shall be for a period
commencing on January&nbsp;1, 2023 (the &ldquo;Commencement Date&rdquo;) and continuing through January&nbsp;1, 2025, the second anniversary
of the Commencement Date. Notwithstanding the foregoing, the Executive&rsquo;s employment by the Company hereunder may be earlier terminated,
subject to <U>Section&nbsp;9</U> hereof, upon the occurrence of any one of the following events: (i)&nbsp;the Company&rsquo;s decision
to terminate the Executive, (ii)&nbsp;the Executive&rsquo;s decision to voluntarily resign or retire at any time or (iii)&nbsp;the parties&rsquo;
mutual agreement in writing to terminate the Executive&rsquo;s employment hereunder at any time. The period of time between the Commencement
Date and termination of the Executive&rsquo;s employment hereunder shall be referred to herein as the &ldquo;Employment Period&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Position
and Services</U>.</B> (i)&nbsp; The Executive will hold the position of <FONT STYLE="background-color: white">Executive Vice President,
Finance, Chief Financial Officer, Chief Operating Officer and Secretary</FONT>. The Executive will report directly to the Company&rsquo;s
President and Chief Executive Officer and shall have such duties, responsibilities and authority with respect to such positions as are
set forth in the Bylaws of the Company, which duties and responsibilities shall in all events include, but not be limited to, management
responsibility for the operations, finance and administration of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Executive will be expected to be in the full-time employment of the Company, to devote substantially all of his business time, attention
and efforts to the performance of his duties hereunder. Notwithstanding the foregoing, the Executive may make and manage personal business
investments of his choice and serve in any capacity with any civic, educational or charitable organization, or any trade association,
without seeking or obtaining approval from the Board and/or the President and Chief Executive Officer, provided such activities and service
do not materially interfere or conflict with the performance of his duties hereunder or violate the non-competition provisions of <U>Section&nbsp;12</U>
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Executive expressly agrees that during the Employment Period he will not be interested, directly or indirectly, in any form, fashion or
manner, as a partner, officer, director, advisor, employee, consultant, controlling stockholder or in any other form or capacity, in any
other business or company, except that he would not be prohibited by <U>Section&nbsp;12</U> hereof to serve as (a)&nbsp;member of one
other Board of Directors of a commercial organization, or (b)&nbsp;a member of one or more Boards of Directors or Trustees of a charitable
organization, as may, upon advance notice from the Executive be approved by the Board in its discretion after consideration of possible
conflicts, reputation(al) effects, time requirements and other interests of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Executive is currently serving as a Class&nbsp;3
director on the Company&rsquo;s Board for a term ending at the 2024 annual meeting. The Board will use its best efforts to cause the nomination
of the Executive thereafter for reelection as a Class&nbsp;3 director to the Board for successive terms, at every time at which Class&nbsp;3
directors are nominated to the stockholders for election, as long as the Executive serves as Executive <FONT STYLE="background-color: white">Vice
President, Finance, Chief Financial Officer, Chief Operating Officer and Secretary </FONT>unless the Executive declines such nomination
in writing to the Board. As with all members of the Board, the Executive&rsquo;s continuation as a director requires election as a director
by the stockholders whenever directors are to be elected by the stockholders. If the Executive ceases to serve as Executive Vice President,
Finance, Chief Financial Officer, Chief Operating Officer and Secretary for any reason, and the Board thereafter requests that the Executive
resigns as a director of the Board, the Executive shall immediately resign as a director of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Base
Salary</U>.</B> Company shall pay to the Executive an initial base salary at an annual rate of &pound;244,622, subject to applicable income
and employment tax withholdings and all other required and authorized payroll deductions and withholdings. The Executive&rsquo;s salary
shall be payable at the same time and basis as the Company pays its payroll in general. Increases in the Executive&rsquo;s annual base
salary during the Employment Period may be effected from time to time based upon the review and approval of the Compensation Committee
of the Board (the &ldquo;Compensation Committee&rdquo;). During the Employment Period, the Executive&rsquo;s base salary rate shall not
be reduced below the initial base salary rate provided hereunder, nor below any increased base salary rate that may be effected as provided
hereunder, except if the Board, in response to exceptionally adverse business circumstances makes a general temporary reduction in the
compensation of the executives of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Annual
Incentive Bonus</U>.</B> In addition to the Executive&rsquo;s base salary as provided above, the Executive will be eligible for an annual
cash incentive bonus for each calendar year of the Employment Period. The bonus for which the Executive is eligible for each such year
will be based on a target percentage of the then current base salary, which target percentage shall be at least 50% of Executive&rsquo;s
then current base salary. The determination of the amount of the annual cash incentive bonus will be based upon the satisfaction of performance
criteria established by the Compensation Committee in its discretion and upon consultation with the Executive at the beginning of each
year and subject to the approval of the Board. Depending on the Executives performance against the performance criteria, the actual annual
cash incentive bonus may be more, equal to or less than the target. Such performance criteria will include corporate performance goals
consistent with the Company&rsquo;s business plan for the year, as well as individual objectives for the Executive&rsquo;s performance
that may be separate from, but are consistent with, the Company&rsquo;s business plan. The final determinations as to the actual corporate
and individual performance against the pre-established goals and objectives, and the amount of the bonus payout in relationship to such
performance, will be made by the Compensation Committee in its sole discretion. To the extent the Company awards the Executive a cash
bonus, the bonus, if payable, shall be calculated and paid no later than two and a half months following the later of the close of the
calendar or Company fiscal year to which such bonus relates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Executive
Benefits</U>.</B> The Executive shall be entitled to receive employment benefits in accordance with the Company&rsquo;s benefit policies
in effect for senior executives employed in the United Kingdom from time to time, including, without limitation, personal pension plan,
private medical, dental and life insurance, accidental death, travel accident, long term disability insurance, profit sharing and long
term incentive plans, 25 working days of paid vacation and 10 days of UK public holidays annually, as established from time to time by
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Expenses</U>.</B>
The Company shall reimburse the Executive for all reasonable and necessary expenses incurred by him in connection with the performance
of his services for the Company upon submission of expense reports and documentation in accordance with the Company&rsquo;s policies.
The Company may request additional documentation or a further explanation to substantiate any expense submitted for reimbursement, and
retains the discretion to approve or deny a request for reimbursement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Indemnification</U>.</B>
The Company shall indemnify the Executive in accordance with the Company&rsquo;s By-laws. The Company agrees that it will make all commercially
reasonable efforts to keep in full force and effect, for the duration of all applicable statute of limitations periods, directors and
officers liability insurance policies on terms at least as favorable to the Executive as those in effect on the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Termination</U>.</B>
This Agreement does not grant the Executive any right or entitlement to be retained by the Company. In the event of termination by the
Company of the Executive&rsquo;s employment under the circumstances described below in this <U>Section&nbsp;9</U>, the Executive shall
be entitled to the severance pay and benefits so specified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain
Definitions</U>. For purposes of this <U>Section&nbsp;9</U>, the following terms shall have the meanings given below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination
For Cause</U>. The employment of the Executive hereunder shall be deemed to have been terminated &ldquo;For Cause&rdquo; if the Company
shall have terminated the Executive as a result of any of the following: (A)&nbsp;any act committed by the Executive which shall represent
a breach in any material respect of any of the terms of this Agreement and which breach is not cured within thirty (30) days of receipt
by the Executive of written notice from the Company of such breach; (B)&nbsp;improper conduct, consisting of any willful act or omission
with the intent of obtaining, to the material detriment of the Company, any benefit to which the Executive would not otherwise be entitled;
(C)&nbsp;gross negligence, consisting of wanton and reckless acts or omissions in the performance of the Executive&rsquo;s duties to the
material detriment of the Company; (D)&nbsp;addiction to drugs or chronic alcoholism or (E)&nbsp;any conviction of, or plea of nolo contendere
to, a crime (other than a traffic violation) under the laws of the United States, the United Kingdom, or any of their respective political
subdivisions, provided that the Executive receives a copy of a resolution duly adopted by a two thirds majority affirmative vote of the
membership of the Board excluding the Executive, at a meeting of the Board called and held for such purpose after the Executive has been
given reasonable notice of such meeting and has been given an opportunity, together with his counsel, to be heard by the Board, finding
that in the good faith opinion of the Board the Executive was guilty of the conduct set forth and specifying the particulars thereof in
detail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination
Without Cause</U>. The employment of the Executive hereunder shall be deemed to have been terminated &ldquo;Without Cause&rdquo; upon
(A)&nbsp;termination of employment by the Company for any reason other than the reasons specified in <U>Section&nbsp;9(a)(i)</U>&nbsp;hereof
as termination &ldquo;For Cause&rdquo; or the reasons specified in <U>Section&nbsp;9(a)(iii)</U>&nbsp;hereof as termination because of
the Executive&rsquo;s Death or Disability, (B)&nbsp;termination of employment by the Company by virtue of the expiry of the Employment
Period on 1 January&nbsp;2025 (or any specific extension thereof), unless the Company has offered in writing to renew the Executive&rsquo;s
employment after the expiry of the Employment Period on terms no less favorable than those provided in this Agreement (in which case if
the Executive does not accept renewal of his employment, the termination of his employment by virtue of expiry of the Employment Term
will be deemed a resignation by the Executive), or (C)&nbsp;termination of employment by the Executive within thirty (30) days following
a &ldquo;Constructive Termination&rdquo; event. For purposes hereof, the following shall constitute Constructive Termination events: (1)&nbsp;any
removal of the Executive from the position of Executive <FONT STYLE="background-color: white">Vice President, Finance, Chief Financial
Officer and Chief Operating Officer</FONT>, (2)&nbsp;any material reduction of the Executive&rsquo;s duties, responsibilities or authority,
including any change in the Executive&rsquo;s positions as Executive <FONT STYLE="background-color: white">Vice President, Finance, Chief
Financial Officer and Chief Operating Officer </FONT>that results in such a reduction, (3)&nbsp;a material reduction by the Company in
the Executive&rsquo;s base salary in effect on the date hereof or as may be increased from time to time except if the Board in response
to exceptional adverse business circumstances makes a general temporary reduction in the compensation of the executives of the Company,
(4)&nbsp;the Company&rsquo;s requiring the Executive without the Executive&rsquo;s express written consent to be based anywhere other
than within 50 miles of the Executive&rsquo;s present office location in the United Kingdom, except for required travel on the Company&rsquo;s
business to an extent substantially consistent with the Executive&rsquo;s present business travel obligations, or (5)&nbsp;a material
breach of this Agreement by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing shall be treated
as Constructive Termination events hereunder following the expiration of 30 days from the date the Executive has notified Company (within
90 days) of the occurrence of such event and the Executive&rsquo;s intention to treat such event as a constructive termination and terminate
the Executive&rsquo;s employment on the basis thereof, provided that Company has not cured the constructive termination event before the
expiration of such 30-day period. The Executive&rsquo;s termination will be effective upon the expiration of the 30-day period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Disability</U>.
The Executive shall be treated as having suffered a &ldquo;Disability&rdquo; if the Executive is prevented from performing his duties
hereunder by reason of illness or injury for a period of either (A)&nbsp;six or more consecutive months from the First Date of Disability
(as defined below) or (B)&nbsp;eight months in the aggregate during any 12-month period. The date as of which the Executive is first absent
from employment as a result of such illness or injury shall be referred to herein as the &ldquo;First Date of Disability&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Change
in Control</U>. A &ldquo;Change in Control&rdquo; shall be deemed to have taken place if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>there
shall be consummated any consolidation or merger of the Company in which Company is not the continuing or surviving corporation or pursuant
to any transaction in which shares of the Company&rsquo;s capital stock are converted into cash, securities or other property, or any
sale, lease, exchange or other transfer in one transaction or a series of transactions contemplated or arranged by any party as a single
plan of all or substantially all of the assets of the Company, or the approval of a plan of complete liquidation or dissolution of the
Company adopted by the stockholders of the Company; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>any
person (as such term is used in <U>Sections 13(d)</U>&nbsp;and 14(d)(2)&nbsp;of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;)) shall after the date hereof become the beneficial owner (as defined in Rules&nbsp;13d-3 and 13d-5 under the Exchange Act),
directly or indirectly, of securities of the Company representing 35% or more of the voting power of all then outstanding securities of
the Company having the right under ordinary circumstances to vote in an election of the Board (including, without limitation, any securities
of the Company that any such person has the right to acquire pursuant to any agreement, or upon exercise of conversion rights, warrants
or options, or otherwise, shall be deemed beneficially owned by such person); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(C)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>individuals
who at the date hereof constitute the entire Board and any new directors whose election by the Board, or whose nomination for election
by the Company&rsquo;s stockholders, shall have been approved by a vote of at least a majority of the directors then in office who either
were directors at the date hereof or whose election or nomination for election shall have been so approved (the &ldquo;Continuing Directors&rdquo;)
shall cease for any reason to constitute a majority of the members of the Board; and <U>provided further</U> that in each of the foregoing
cases, the Change of Control also meets all of the requirements of a &ldquo;change in the ownership of a corporation&rdquo; within the
meaning of Treasury Regulation &sect;1.409A-3(i)(5)(v), a &ldquo;change in the effective control of a corporation&rdquo; within the meaning
of Treasury Regulation &sect;1.409A-3(i)(5)(vi)&nbsp;or a &ldquo;a change in the ownership of a substantial portion of the corporation&rsquo;s
assets&rdquo; within in the meaning of Treasury Regulation &sect;1.409A-3(i)(5)(vii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination
Without Cause</U>. In the event of termination of the Executive&rsquo;s employment hereunder by Company &ldquo;Without Cause&rdquo; (other
than for a Termination for a Change of Control hereinafter separately provided for) the Executive shall be entitled to the following severance
pay and benefits:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Severance
Pay</I> - severance payments in the form of continuation of the Executive&rsquo;s base salary as in effect immediately prior to such termination
for a period of twelve (12) months following the effective date of such termination;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Benefits
Continuation</I> &ndash; continued coverage under the Company&rsquo;s private medical care and life insurance benefit plans in which the
Executive is participating at the time of termination, or equivalent coverage thereof, on the same terms as applicable to other executive
employees of the Company from time to time, over the same period with respect to which the Executive&rsquo;s base salary is continued
as provided in <U>Section&nbsp;9(b)(i)</U>&nbsp;hereof; <U>provided</U>, <U>however</U>, that the Company&rsquo;s obligation to provide
such coverages shall be terminated if the Executive obtains substitute coverage from another employer of the Executive at any time during
the continuation period; the Executive shall be obligated to notify the Company of any such substitute coverage and the date of commencement
thereof promptly upon obtaining any such coverage; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Stock
Options</I> - all options to purchase shares of the Company&rsquo;s common stock held by the Executive and which are vested immediately
prior to termination of employment shall become exercisable for a period of six months following the effective date of termination of
employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination
following Change in Control</U>. In the event of termination of the Executive&rsquo;s employment within six months following a Change
of Control the Executive shall be entitled to the following severance pay and benefits:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Severance
Pay</I> - Severance payments in the form of continuation as the Executive&rsquo;s base salary as in effect immediately prior to such termination
for a period of twelve (12) months following the effective date of termination;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Benefits
Continuation</I> &ndash; continued coverage under the Company&rsquo;s private medical care and life insurance benefit plans in which the
Executive is participating at the time of termination, or equivalent coverage thereof, on the same terms as applicable to other executive
employees of the Company from time to time, over the same period with respect to which the Executive&rsquo;s base salary is continued
as provided in <U>Section&nbsp;9(b)(i)</U>&nbsp;hereof; <U>provided</U>, <U>however</U>, that the Company&rsquo;s obligation to provide
such coverages shall be terminated if the Executive obtains substitute coverage from another employer of the Executive at any time during
the continuation period; the Executive shall be obligated to notify the Company of any such substitute coverage and the date of commencement
thereof promptly upon obtaining any such coverage; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Stock
Options</I> - all options to purchase shares of the Company&rsquo;s common stock held by the Executive shall be vested and be exercisable
for a period of 18 months following the effective date of termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>280G
Excise Tax</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(A)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>It
is the intention of Executive and the Company that no payments made or benefits provided by the Company to or for the benefit of Executive
under this Agreement or any other agreement or plan pursuant to which Executive is entitled to receive payments or benefits shall be subject
to the excise tax imposed on the Executive by Section&nbsp;4999 of the Code (the &ldquo;280G Excise Tax&rdquo;), relating to golden parachute
payments. The Company agrees that in the event any payments to Executive pursuant to this Agreement would result in a payment to Executive
that would trigger any 280G Excise Tax, if appropriate and permissible, the Company shall submit to its stockholders for approval the
transaction that may result in the imposition of the 280G Excise Tax upon Executive in accordance with the regulations of the Internal
Revenue Code governing shareholder approval of transactions giving rise to 280G Excise Tax liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(B)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If
the Company is unable to submit to its stockholders for approval the transaction that may result in the imposition of the 280G Excise
Tax and to the extent that any payment, benefit or distribution of any type to or for the benefit of the Executive by the Company or any
of its affiliates, whether paid or payable, provided or to be provided, or distributed or distributable pursuant to the terms of this
Agreement or otherwise (including, without limitation, any accelerated vesting of stock options or other equity-based awards) (collectively,
the &ldquo;<U>Total Payments</U>&rdquo;) would be subject to the 280G Excise Tax, then the Total Payments shall be reduced (but not below
zero) so that the maximum amount of the Total Payments (after reduction) shall be one dollar ($1.00) less than the amount which would
cause the Total Payments to be subject to the 280G Excise Tax, but only if the Total Payments so reduced result in the Executive receiving
a net after tax amount that exceeds the net after tax amount the Executive would receive if the Total Payments were not reduced and were
instead subject to the 280G Excise Tax. If a reduction is required, the Company shall reduce or eliminate the Total Payments by first
reducing or eliminating any cash severance benefits (with the payments to be made furthest in the future being reduced first), then by
reducing or eliminating any accelerated vesting of stock options or similar awards, then by reducing or eliminating any accelerated vesting
of restricted stock or similar awards, then by reducing or eliminating any other remaining Total Payments. The preceding provisions of
this Section&nbsp;shall take precedence over the provisions of any other plan, arrangement or agreement governing the Executive&rsquo;s
rights and entitlements to any benefits or compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination
Upon Disability or Death</U>. In the event of termination of the Executive&rsquo;s employment hereunder on account of the Executive&rsquo;s
 &ldquo;Disability&rdquo; or death, the Executive or the Executive&rsquo;s heirs, estate or personal representatives under law, as applicable,
shall be entitled to the following severance pay and benefits:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Severance
Pay</I> - severance payments in the form of continuation of the Executive&rsquo;s base salary as in effect immediately prior to such termination
for a period of 12 months following the First Date of Disability, reduced by the amounts of any payments received from any long-term disability
plan of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Benefits
Continuation</I> - the same benefits as provided in <U>Section&nbsp;9(c)(ii)</U>&nbsp;above, to be provided during the Employment Period
while the Executive is suffering from Disability and for a period of twelve (12) months following the effective date of termination of
employment by reason of Disability; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Stock
Options</I> - all options to purchase shares of the Company&rsquo;s common stock held by the Executive which are exercisable immediately
prior to termination of employment shall remain exercisable for a period of twelve (12) months following the effective date of termination
of employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Other
Terminations</U>. In the event of termination of the Executive&rsquo;s employment hereunder for any reason other than those specified
in subsections (b)&nbsp;through (d)&nbsp;of this <U>Section&nbsp;9</U>, the Executive shall not be entitled to any severance pay, benefits
continuation or stock option rights contemplated by the foregoing provisions of this <U>Section&nbsp;9</U>, except as otherwise provided
in the applicable benefit plans of the Company that cover the Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Accrued
Rights</U>. Notwithstanding the foregoing provisions of this <U>Section&nbsp;9</U>, in the event of termination of the Executive&rsquo;s
employment hereunder for any reason, the Executive shall be entitled to payment of any unpaid portion of his base salary, computed on
a pro-rata basis through the effective date of termination, and payment of any accrued but unpaid rights in accordance with the terms
of any incentive bonus or employee benefit plan or program of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions
to Severance Benefits</U>. (i)&nbsp; As conditions of the Executive&rsquo;s entitlement and continued entitlement to the severance payments
and benefits provided by this <U>Section&nbsp;9</U>, the Executive is required to (i)&nbsp;honor in accordance with their terms the provisions
of <U>Sections 10, 11 and 12</U> hereof and (ii)&nbsp;execute and honor the terms of a waiver and release of claims against the Company
substantially in the form attached hereto as <U>Exhibit&nbsp;A</U> (as may be modified consistent with the purposes of such waiver and
release to reflect changes in law following the date hereof) and compromise agreement in the form attached hereto as <U>Exhibit&nbsp;B</U>
(as may be modified consistent with the purposes of such compromise agreement to reflect changes in law following the date hereof). The
parties hereto agree that the Executive is under no affirmative obligation to seek to mitigate or offset the severance payments and benefits
provided by this <U>Section&nbsp;9</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
purposes only of this Section, the Executive shall be treated as having failed to honor the provisions of <U>Sections 10, 11 or 12</U>
hereof only upon the passing of a resolution by a majority of the Board making such a determination following notice of the alleged failure
by Company to the Executive, an opportunity for the Executive to cure the alleged failure for a period of thirty (30) days from the date
of such notice and the Executive&rsquo;s opportunity to be heard on the issue by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Stock
Options</I> - Notwithstanding any other provisions of this Agreement to the contrary, in the event that the Executive continues to serve
as a member of the Board following his termination of employment from Company, his rights with respect to the vesting and exercisability
of the options shall continue in the same manner as other non-executive members of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Confidentiality</U>.</B>
The Executive agrees that he will not at any time during the term hereof or thereafter for any reason, in any fashion, form or manner,
either directly or indirectly, divulge, disclose or communicate to any person, firm, corporation or other business entity, in any manner
whatsoever, any confidential information or trade secrets concerning the business of the Company (including the business of any unit thereof),
including, without limiting the generality of the foregoing, the names of any of its customers, the prices at which it obtains or has
obtained any products or services, the techniques, methods or systems of its operation or management, any customer proposals or other
business opportunities, any information regarding its financial matters, or any other material information concerning the business of
the Company, its manner of operation, its plans or other material data. The provisions of this paragraph shall not apply to (i)&nbsp;information
disclosed in the performance of the Executive&rsquo;s duties to the Company based on his good faith belief that such a disclosure is in
the best interests of the Company; (ii)&nbsp;information that is public knowledge; (iii)&nbsp;information disseminated by the Company
to others in the ordinary course of the Company&rsquo;s business, in order to further such business, provided the recipient of such information
agrees to be subject to a confidentiality obligation at least comparable to that herein; (iv)&nbsp;information or knowledge lawfully received
by the Executive from a third party who, based upon due inquiry by the Executive, is not bound by a confidential relationship to the Company;
or (v)&nbsp;information disclosed under a requirement of law or as directed by applicable legal authority having jurisdiction over the
Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Inventions</U>.</B>
(i)&nbsp; To the extent that any of the Company&rsquo;s current or future products or services relate to, embody or incorporate concepts,
technology or products of any kind relevant to the Company or its subsidiaries or affiliates that the Executive directly or indirectly
conceived or developed prior to the date hereof during the period of his employment by Company (&ldquo;Prior Technology&rdquo;), the Executive
assigns in perpetuity to Company any and all of his rights, title and interests, if any, to utilize, without any cost to the Company,
such Prior Technology, and the Executive agrees to assist Company in taking all action that may be reasonably required, at the Company&rsquo;s
expense, to secure for the Company the benefits of the Executive&rsquo;s ownership or rights, if any, to use all such Prior Technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Executive is hereby retained in a capacity such that the Executive&rsquo;s responsibilities include the making of technical, managerial
and promotional contributions of value to the Company. The Executive hereby assigns to Company all rights, title and interest in such
contributions and inventions made or conceived by the Executive alone or jointly with others which relate to the business of the Company.
This assignment shall include (a)&nbsp;the right to file and prosecute patent applications on such inventions in any and all countries,
(b)&nbsp;the patent applications filed and patents issuing thereon, and (c)&nbsp;the right to obtain copyright, trademark or trade name
protection for any such work product. The Executive shall promptly and fully disclose all such contributions and inventions to the Company
and assist the Company in obtaining and protecting the rights therein (including patents thereon), in any and all countries; provided,
however, that said contributions and inventions will be the property of the Company, whether or not patented or registered for copyright,
trademark or trade name protection, as the case may be. Inventions conceived by the Executive which are not related to the business of
the Company (as determined in good faith by the Board), will remain the property of the Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Non-Competition</U>.</B>
(i)&nbsp; the Executive agrees that he shall not during the Employment Period and for a period of one year after the termination or end
thereof for any reason, without the approval of the Board which, after the end of the Employment Period, shall not unreasonably be withheld
or delayed, directly or indirectly, alone or as partner, joint venturer, officer, director, employee, consultant, agent, independent contractor
or controlling stockholder (other than as provided below) of any Company or business, engage in any &ldquo;Competitive Business&rdquo;
within the United States or within the United Kingdom and which directly competes with the business of the Company and/or Cyclacel Limited.
For purposes of the foregoing, the term &ldquo;Competitive Business&rdquo; shall mean any business involved in and/or intending to seek
marketing approvals of drug candidates belonging to the same pharmaceutical class as the candidates under development by the Company from
time to time, currently CDK inhibitors, PLK inhibitors and nucleoside analogues; provided that, this provision shall in no way prevent
the Executive, after the end of the Employment Period, from being employed as a consultant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
the provisions of clause (i)&nbsp;above or any other provision of this Agreement to the contrary, the Executive shall not be prohibited
during the period applicable under clause (i)&nbsp;above from acting as a passive investor where (a)&nbsp;in the case of a Competitive
Business being a public corporation, the Executive owns not more than five percent (5%) of the issued and outstanding capital stock or
such higher percentage or amount as may be approved by the Board upon notice from the Executive prior to obtaining such interest; provided,
however, that the Executive shall not be treated as having violated the provisions of this <U>Section&nbsp;12</U> if in good faith he
is unaware that an entity in which he has an investment interest would be treated as a Competitive Business and, upon becoming aware of
such involvement, the Executive makes reasonable efforts to divest himself of his interest in such business; (b)&nbsp;in the case of any
employer or entity other than a Competitive Business that is engaged in, or whose affiliates are engaged in, the development or marketing
of products or technologies that are directly or indirectly competitive with any product or technology that is developed or marketed or
proposed to be developed or marketed by Company during the Employment Period, the Executive owns not more than five percent (5%) of the
issued and outstanding capital stock; or (c)&nbsp;receiving stock, options or warrants from any entity with which the Executive can have
a relationship pursuant to clause (i)&nbsp;above as part of the Executive&rsquo;s compensation for services rendered or to be rendered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Breach
of Restrictive Covenants</U>.</B> The parties agree that a breach or violation of <U>Sections 10, 11 or 12</U> hereof will result in immediate
and irreparable injury and harm to the innocent party, who shall have, in addition to any and all remedies of law and other consequences
under this Agreement, the right to an injunction, specific performance or other equitable relief to prevent the violation of the obligations
hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Non-Disparagement</U></B>.
</FONT>The Executive agrees that he will not, whether during his provision of services to the Company or thereafter, directly or indirectly,
make, cause to be made, or ratify any statement, public or private, oral or written, to any person that disparages, either professionally
or personally, the Company or any of its affiliates, past and present, and each of them, as well as its and their trustees, directors,
officers, agents, attorneys, insurers, employees, stockholders, representatives, assigns, and successors, past and present, and each of
them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Whistleblower;
Defend Trade Secrets Act</U></B>. Nothing in this Agreement shall prohibit the Executive from reporting possible violations of federal
law or regulation to any governmental agency or entity including but not limited to the Department of Justice, the Securities and Exchange
Commission, the Equal Employment Opportunity Commission, and any Inspector General, or making other disclosures that are protected under
the whistleblower provisions of federal law or regulation. The Executive does not need the prior authorization of the Company to make
any such reports or disclosures and the Executive is not required to notify the Company that the Executive has made such reports or disclosures.
Under the Defend Trade Secrets Act of 2016, the Company hereby provides notice and Executive hereby acknowledges that Executive may not
be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i)&nbsp;is
made (A)&nbsp;in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney and (B)&nbsp;is
solely for the purpose of reporting or investigating a suspected violation of law; or (ii)&nbsp;is made in a complaint or other document
filed in a lawsuit or other proceeding, if such filing is made under seal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Notices</U>.</B>
Any notice required to be given pursuant to the provisions of this Agreement shall be in writing and, if mailed, sent by registered mail,
postage prepaid, to the party named at the address set forth below, or at such other address as each party may hereafter designate in
writing to the other party:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 1in">Company:</TD><TD>200 Connell Drive #1500<BR>
Berkeley Heights, NJ 07922<BR>
Attention: Chairman of the Board</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-indent: -1in">with a copy to (which copy will not constitute
notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-indent: -1in">Mintz Levin Cohn Ferris Glovsky&nbsp;&amp;
Popeo, P.C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-indent: 0in">919 Third Avenue<BR>
New York, New York 10022<BR>
Attention: Joel Papernik,&nbsp;Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 1in">Executive:</TD><TD>c/o Cyclacel Pharmaceuticals,&nbsp;Inc.<BR>
200 Connell Drive #1500<BR>
Berkeley Heights, NJ 07922</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any such notices shall be deemed to have been
delivered when served personally in the manner specified above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Dispute
Resolution</U>.</B> The parties shall waive trial by jury in any dispute between them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Entire
Agreement</U>.</B> (a)&nbsp; <I>Change, Modification, Waiver</I>. No change or modification of this Agreement shall be valid unless it
is in writing and signed by each of the parties hereto. No waiver of any provision of this Agreement shall be valid unless it is in writing
and signed by the party against whom the waiver is sought to be enforced. The failure of a party to insist upon strict performance of
any provision of this Agreement in any one or more instances shall not be construed as a waiver or relinquishment of the right to insist
upon strict compliance with such provision in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Integration
of All Agreements</I>. This Agreement constitutes the entire Agreement between the parties and is intended to be an integration of all
agreements between the parties with respect to the Executive&rsquo;s service with Company. Except as provided in <U>Section&nbsp;8</U>
hereof concerning the Indemnification Agreement, any and all prior agreements between the Executive and the Company with respect to the
Executive&rsquo;s service with the Company are hereby revoked.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Severability
of Provisions</I>. If for any reason any provision of this Agreement should be declared void or invalid, such declaration shall not affect
the validity of the rest of this Agreement, which shall remain in force as if executed with the void or invalid provision eliminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Binding
Effect</U>.</B> This Agreement shall be binding upon all parties hereto and their heirs, successors and assigns. This Agreement shall
be assignable by Company to any entity acquiring all or substantially all of the assets of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Governing
Law</U>.</B> This Agreement shall be governed by and construed in accordance with the laws of the State of New Jersey, except that, and
only to the extent applicable, England law shall govern the working conditions and the like.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Miscellaneous</U>.</B>
(a)&nbsp; <I>Form</I>. As employed in this Agreement, the singular form shall include, if appropriate, the plural.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Headings</I>.
The headings employed in this Agreement are solely for the convenience and reference of the parties and are not intended to be descriptive
of the entire contents of any paragraph and shall not limit or otherwise affect any of terms, provisions, or construction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Modifications</I></FONT>.
Notwithstanding any other provision with respect to the timing of payments under this Agreement, if, at the time of Executive&rsquo;s
expiration of the Employment Period, the non-renewal of the Executive&rsquo;s employment is deemed to be dismissal or termination (within
the meaning of the UK law or any other applicable law), limited only to the extent necessary to comply with the requirements of the UK
law, any payment to which Executive may become entitled under the UK law will be withheld, but no later than the first (1st) business
day of the 11th week following the expiration of the Employment Period, at which time the parties to this Agreement will be negotiate
in good faith a mechanism effective under the UK law to carry out the intent and purpose of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Additional
Terms of Statement of Main Terms and Conditions of Employment</U>.</B> The parties shall execute and deliver a Statement of Main Terms
and Conditions of Employment as required by UK law and conforming, to the extent practicable, with the terms and conditions of the foregoing
..</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>[signature
page&nbsp;follows]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I></I></FONT><B>IN WITNESS WHEREOF,</B> this Agreement is executed as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left"><FONT STYLE="font-size: 10pt">Cyclacel Pharmaceuticals,&nbsp;Inc.:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: left"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><FONT STYLE="font-size: 10pt"><U>/s/ Spiro Rombotis</U></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt"><U>Spiro Rombotis_</U></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt"><U>President and Chief Executive
    Officer</U></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left"><FONT STYLE="font-size: 10pt">Paul McBarron:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">/s/ Paul McBarron</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><U>Exhibit&nbsp;A</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Waiver and Release</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><B><U>Your
Release of Claims.</U></B> You hereby agree and acknowledge that by signing this Agreement, and for other good and valuable consideration,
you are waiving your right to assert any and all forms of legal claims against the Company<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>1</SUP></FONT><SUP>/</SUP>
of any kind whatsoever, whether known or unknown, arising from the beginning of time through the date you execute this Agreement (the
 &ldquo;Execution Date&rdquo;). Except as set forth below, your waiver and release herein is intended to bar any form of legal claim, complaint
or any other form of action (jointly referred to as &ldquo;Claims&rdquo;) against the Company seeking any form of relief including, without
limitation, equitable relief (whether declaratory, injunctive or otherwise), the recovery of any damages, or any other form of monetary
recovery whatsoever (including, without limitation, back pay, front pay, compensatory damages, emotional distress damages, punitive damages,
attorneys fees and any other costs) against the Company, for any alleged action, inaction or circumstance existing or arising through
the Execution Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Without limiting the foregoing general waiver and
release, you specifically waive and release the Company from any Claim arising from or related to your prior employment relationship with
the Company or the termination thereof, including, without limitation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">**</TD><TD STYLE="text-align: justify">Claims under any state or federal discrimination, fair employment practices or other employment related statute, regulation or executive
order (as they may have been amended through the Execution Date) prohibiting discrimination or harassment based upon any protected status
including, without limitation, race, national origin, age, gender, marital status, disability, veteran status or sexual orientation. Without
limitation, specifically included in this paragraph are any Claims arising under the Age Discrimination in Employment Act, Title VII of
the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Americans With Disabilities Act and any similar Federal and state statute.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">**</TD><TD STYLE="text-align: justify">Claims under any other state or federal employment related statute, regulation or executive order (as they may have been amended through
the Execution Date) relating to wages, hours or any other terms and conditions of employment.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">**</TD><TD STYLE="text-align: justify">Claims under any state or federal common law theory including, without limitation, wrongful discharge, breach of express or implied
contract, promissory estoppel, unjust enrichment, breach of a covenant of good faith and fair dealing, violation of public policy, defamation,
interference with contractual relations, intentional or negligent infliction of emotional distress, invasion of privacy, misrepresentation,
deceit, fraud or negligence.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT><SUP>/</SUP></TD><TD STYLE="text-align: justify">For purposes of this Agreement, the Company includes the Company
and any of its divisions, affiliates (which means all persons and entities directly or indirectly controlling, controlled by or under
common control with the Company), subsidiaries and all other related entities, and its and their directors, officers, employees, trustees,
agents, successors and assigns.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">**</TD><TD>Any other Claim arising under state or federal law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Notwithstanding
the foregoing, nothing contained in this Release constitutes a waiver of </FONT>any Claims you may have against the Company arising from
or related to the Indemnification Agreement and By-laws provisions referenced in Section&nbsp;8 of the Employment Agreement, dated January&nbsp;1,
2014, entered into between you and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You acknowledge and agree that, but for providing
this waiver and release, you would not be receiving the economic benefits being provided to you under the terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>It is the Company&rsquo;s desire and intent
to make certain that you fully understand the provisions and effects of this Agreement. To that end, you have been encouraged and given
the opportunity to consult with legal counsel for the purpose of reviewing the terms of this Agreement. Also, because you are over the
age of 40 and consistent with the provisions of the Age Discrimination in Employment Act (&ldquo;ADEA&rdquo;), which prohibits discrimination
on the basis of age, the Company is providing you with twenty-one (21) days in which to consider and accept the terms of this Agreement
by signing below and returning it to me at: [name], [address].</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>You may rescind your assent to this Agreement
if, within seven (7)&nbsp;days after you sign this Agreement, you deliver by hand or send by mail (certified, return receipt and postmarked
within such 7 day period) a notice of rescission to me at the Company. The eighth day following your signing of this Agreement is the
Effective Date.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Also, nothing in this Agreement: (i)&nbsp;prohibits
or restricts you from filing a charge or complaint against the Company with any federal, state or local government authority, including
a charge of unlawful discrimination with the Equal Employment Opportunity Commission or a state or local government authority responsible
for enforcing laws prohibiting discriminatory employment practices; (ii)&nbsp;prohibits or restricts you from communicating with, providing
relevant information to or otherwise cooperating with any government authority, including the EEOC or a state or local government authority
responsible for enforcing laws prohibiting discriminatory employment practices, including without limitation, responding to any inquiry
from such government authority, including an inquiry about the existence of this Agreement or its underlying facts; or (iii)&nbsp;requires
you to notify the Company of your communications with or inquiries from any government authority. To the maximum extent permitted by law,
however, you are not entitled to recover any legal or equitable remedies, including reinstatement or monetary damages, in the case of
any administrative claim that he files or in which he participates, except as set forth herein and except that he retains the right to
receive an award for actionable information he provides to a government authority. .</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 46%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Paul McBarron</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%">Date signed:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 41%">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><U>Exhibit&nbsp;B</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Compromise Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
COMPROMISE AGREEMENT (the &ldquo;<B>Agreement</B>&rdquo;) is made as of [</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT>]
by and between Cyclacel Pharmaceuticals,&nbsp;Inc. (the &ldquo;<B>Employer</B>&rdquo;) and Paul McBarron (the &ldquo;<B>Executive</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Employer has employed the Executive as Executive Vice President, Finance, Chief Financial Officer, Chief Operating Officer and Secretary
since [</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&bull;</FONT>]; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">WHEREAS, the Executive may have certain claims
against the Employer in respect of the Executive&rsquo;s employment during the period of the Executive&rsquo;s employment with the Employer
and up to the date of signing of this Agreement by the parties, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">WHEREAS, without admitting the validity of all
or any of these claims, the Employer wishes to settle with the Executive;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOW THEREFORE THE PARTIES AGREE AS FOLLOWS:-</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify"><U>Claims against the Employer</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">a.</TD><TD STYLE="text-align: justify">The Executive asserts that the Executive may have the following particular claims (the &ldquo;<B>Asserted
Claims</B>&rdquo;), and no other claims, against the Employer, its directors, officers or employees, or against any associated company
or person, or any affiliates of the Employer (collectively, the &ldquo;<B>Affiliates</B>&rdquo;) arising from the Executive&rsquo;s employment
with the Employer or the termination thereof:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">i.</TD><TD STYLE="text-align: justify">Any claim for damages for breach of contract for notice or pay in lieu of notice;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">ii.</TD><TD STYLE="text-align: justify">Any claim for holiday pay; or payment of an accrued untaken holiday entitlement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">iii.</TD><TD STYLE="text-align: justify">Any claim for outstanding pay, overtime, expenses, ex-gratia or discretionary payments, use of Company
vehicle, Directors&rsquo; fees, bonuses or commission and also including a claim under the Equal Pay Act 1970 or Article&nbsp;119 of the
Treaty of Rome (as amended by the Treaty of Amsterdam);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">iv.</TD><TD STYLE="text-align: justify">A claim by the Executive for breach of contract by the Employer;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">v.</TD><TD STYLE="text-align: justify">Any claim for unfair dismissal; or unfair constructive dismissal;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">vi.</TD><TD STYLE="text-align: justify">Any claim for unlawful deduction from wages under Part&nbsp;II of the Employment Rights Act 1996;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">vii.</TD><TD STYLE="text-align: justify">Any claim for redundancy payment whether statutory or otherwise;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">viii.</TD><TD STYLE="text-align: justify">Any claim for a failure to follow the statutory dispute resolution procedures under the Employment Act
2002 and the Employment Act 2002 (Dispute Resolution) Regulations 2004;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">ix.</TD><TD STYLE="text-align: justify">Any claim for breach of the Working Time Regulations 1998 including non-payment of holiday pay;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">x.</TD><TD STYLE="text-align: justify">Any claim for failure to give a Statement of Main Terms and Conditions of Employment or dispute resolution
procedures in terms of Part&nbsp;I of the Employment Rights Act 1996;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">b.</TD><TD STYLE="text-align: justify">The Executive confirms that the Executive&rsquo;s only claims or complaints against the Employer or Affiliates
are the Asserted Claims and that the Executive is aware of no other claim or grounds to make a claim against the Employer or Affiliates
in relation to any other matters howsoever arising.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">c.</TD><TD STYLE="text-align: justify">The Executive accepts the terms of this Agreement in full and final settlement of the Asserted Claims
and all other claims, complaints, costs, expenses or rights of action of any kind, present, future or contingent, which the Executive
may have against the Employer or Affiliates, whether under statute, contract or at common law or under legislation or directives of the
European Union, arising from the Executive&rsquo;s employment with the Employer or the termination thereof, including, but not limited
to:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">i.</TD><TD STYLE="text-align: justify">Any claim for sex discrimination or victimisation, or harassment under the Sex Discrimination Act 1975;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">ii.</TD><TD STYLE="text-align: justify">Any claim for race discrimination or victimisation, or harassment under the Race Relations Act 1976;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">iii.</TD><TD STYLE="text-align: justify">Any claim for disability discrimination or victimisation or harassment under the Disability Discrimination
Act 1995;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">iv.</TD><TD STYLE="text-align: justify">Any claim for discrimination, victimisation or harassment under the Employment Equality (Sexual Orientation)
Regulations 2003;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">v.</TD><TD STYLE="text-align: justify">Any claim for discrimination, victimisation or harassment under the Employment Equality (Religion or Belief)
Regulations 2003;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">vi.</TD><TD STYLE="text-align: justify">Any claim for discrimination, victimisation or harassment under the Employment Equality (Age) Regulations
2006;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">vii.</TD><TD STYLE="text-align: justify">Any claim for less favourable treatment, detriment, unfair dismissal or victimisation under the Part&nbsp;Time
Workers (Prevention of Less Favourable Treatment) Regulations 2000;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 13.5pt">viii.</TD><TD STYLE="text-align: justify">Any claim for less favourable treatment, detriment, unfair dismissal or victimisation under the Fixed
Term Executives (Prevention of Less Favourable Treatment) Regulations 2002;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">ix.</TD><TD STYLE="text-align: justify">Any claim under the National Minimum Wage Act 1998;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">x.</TD><TD STYLE="text-align: justify">Any claim in relation to trade union membership, unfair dismissal or detriment on the grounds they are
a trade union member under the Trade Union and Labour Relations (Consolidation) Act 1992;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">xi.</TD><TD STYLE="text-align: justify">Any claim for a protective award under Trade Union and Labour Relations (Consolidation) Act 1992;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">xii.</TD><TD STYLE="text-align: justify">Any claim for harassment under the Protection from Harassment Act 1997;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">xiii.</TD><TD STYLE="text-align: justify">Any claim under Part&nbsp;VII of the Transnational Information and Consultation of Executives Regulations
1999;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">xiv.</TD><TD STYLE="text-align: justify">Any claim for compensation under the Data Protection Act 1998;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">xv.</TD><TD STYLE="text-align: justify">Any claim under Part&nbsp;VIII of the Information and Consultation of Executives Regulations 2004;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">xvi.</TD><TD STYLE="text-align: justify">Any claim for a protective award under the Transfer of Undertakings (Protection of Employment) Regulations
2006;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">xvii.</TD><TD STYLE="text-align: justify">Any claim for a guarantee payment in terms of Part&nbsp;III of the Employment Rights Act 1996;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">xviii.</TD><TD STYLE="text-align: justify">Any claim by the Executive that they have suffered a detriment on the grounds of provisions relating to:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">health and safety;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">Sunday working;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">the Working Time Regulations 1998;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD STYLE="text-align: justify">undertaking duties of an Occupational Pension Scheme Trustee;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(e)</TD><TD STYLE="text-align: justify">undertaking duties as an Executive representative;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(f)</TD><TD STYLE="text-align: justify">time off work for study or training;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(g)</TD><TD STYLE="text-align: justify">protected disclosures;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(h)</TD><TD STYLE="text-align: justify">family leave;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD STYLE="text-align: justify">dependant leave;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(j)</TD><TD STYLE="text-align: justify">flexible working;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(k)</TD><TD STYLE="text-align: justify">enforcing or securing the benefit of or right conferred under the Tax Credits Act 2002.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">all in terms of Sections 44 to 48 of
the Employment Rights Act 1996;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">xix.</TD><TD STYLE="text-align: justify">Any claim for compensation under Section&nbsp;80H of the Employment Rights Act 1996 (flexible working),
but excluding any claims in relation to accrued pension rights or any claims for damages for personal injuries, in respect of the latter
of which the Executive warrants that the Executive is not aware of any such claims.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">d.</TD><TD STYLE="text-align: justify">The Executive warrants that, at the date of this Agreement, the Executive has not issued any proceedings
against the Employer or Affiliates, whether in an Employment Tribunal or otherwise, and agrees to withdraw any such proceedings instituted
on their behalf.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">e.</TD><TD STYLE="text-align: justify">If the waiver of the Asserted Claims or any other claims contained in this Clause is judged to be void
or unenforceable, but would be valid if any one or more of the waivers were reduced, the waiver(s)&nbsp;shall be deemed to apply with
such modification(s)&nbsp;as may be necessary to make them valid and effective. Any such modification of any one waiver of a claim shall
not affect the validity of any other waiver of claim contained in this contract.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify"><U>Executive warranties</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">a.</TD><TD STYLE="text-align: justify">The Executive warrants that he is not aware of any matters relating his employment which if disclosed
to the Employer might affect the Employer&rsquo;s decision to enter into this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">b.</TD><TD STYLE="text-align: justify">The Executive warrants that the Executive has complied with all of his obligations to the Employer and
have not done or failed to do anything which would have allowed the Employer to terminate the Executive employment with immediate effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify"><U>Legal Advice</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">a.</TD><TD STYLE="text-align: justify">The Executive warrants to the Employer that before signing this Agreement the Executive received independent
legal advice from [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
Solicitor, [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
a qualified lawyer (&ldquo;The Advisor&rdquo;), as to the terms and effects of this Agreement, and, in particular, its effect on the Executive&rsquo;s
ability to pursue the Executive&rsquo;s rights before an Employment Tribunal or a Court. The Advisor has in force a Policy of Insurance
covering the risk of a claim by the Executive in respect of any loss arising in consequence of the said legal advice.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">b.</TD><TD STYLE="text-align: justify">The Executive warrants to the Employer that the Executive has provided the Advisor with all available
information which the Advisor requires or may require to advise whether the Executive has any claims, and in particular any of the claims
listed in Clause 1 of this Agreement, against the Employer or Affiliates.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">c.</TD><TD STYLE="text-align: justify">The Executive warrants to the Employer that the Advisor has advised the Executive that on the basis of
the information available to the Advisor the Executive&rsquo;s only claims or particular complaints against the Employer or Affiliates
are the Asserted Claims and that he has no other claim against the Employer whether statutory or otherwise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify"><U>Compliance with statutory provisions</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">a.</TD><TD STYLE="text-align: justify">The Executive declares and acknowledges that the Executive has carefully read and fully understands all
of the provisions of this Agreement and voluntarily agrees to and intends to be legally bound by all its terms and in particular the Executive
acknowledges that this Agreement is a Compromise Agreement within the meaning of s.203(2)(f)&nbsp;of the Employment Rights Act 1996 and
that by entering into this Agreement the Executive has agreed not to institute or continue any proceedings before an Employment Tribunal
or the Courts arising out of the termination of the Executive&rsquo;s employment.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">b.</TD><TD STYLE="text-align: justify">The Employer and the Executive agree and acknowledge that the conditions regulating Compromise Agreements
under Section&nbsp;203(3)&nbsp;of the Employment Rights Act 1996, Section&nbsp;288 of the Trade Union and Labour Relations (Consolidation)
Act 1992; Section&nbsp;77(4A) of the Sex Discrimination Act 1975; Section&nbsp;72(4A) of the Race Relations Act 1976; Schedule 3A of the
Disability Discrimination Act 1995 and Regulation 35(3)&nbsp;of the Working Time Regulations 1998, Section&nbsp;49 of the National Minimum
Wage Act 1998, Regulation 10 of the Fixed Term Executives (Prevention of less favourable Treatment) Regulations 2002; Regulation 9 of
the Part&nbsp;Time Workers (Prevention of Less favourable Treatment) Regulations 2000, Schedule 4 of the Employment Equality (Religion
or Belief) Regulations 2003, Schedule 4 of the Employment Equality (Sexual Orientation) Regulations 2003; Schedule 5 of the Employment
Equality (Age) Regulations 2006; Regulation 40 of the Information and Consultation of Executives Regulations 2004; and Regulation 41 of
the Transnational information and Consultation of Executives Regulations 1998 all as maybe re-enacted or amended are intended to be and
have been satisfied and that the Executive has intimated the foregoing claims.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">IN WITNESS WHEREOF
these presents consisting of this and the [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] preceding pages&nbsp;are executed as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">They are subscribed
for and on behalf of the Employer at [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">on the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;day
of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] 20__ the presence of
the following witness by:-</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(Witness)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 45%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: right">(Authorised Signatory)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(Full Name)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(Address)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(Occupation)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">They are subscribed by the Executive at [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">on the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;day
of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] 20__ in</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">the presence of the following witness:-</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(Witness)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 45%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: right">[Executive&rsquo;s name]</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(Full Name)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(Address)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(Occupation)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.</FONT></TD><TD STYLE="text-align: justify">Solicitor&rsquo;s Certificate under Section&nbsp;203 of the
Employment Rights Act 1996</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
hereby certify as follows:-</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">I am a solicitor holding a current Practising Certificate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">I have advised [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Executive&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]
of the terms and effects of the attached Agreement and in particular its effect on the Executive&rsquo;s ability to pursue a claim to
an Employment Tribunal and/or the Courts following its signing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">I am not acting and have not acted in relation to this matter for [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;employer&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify">There is in force a policy of insurance covering the risk of a claim by the Executive in respect of loss
arising in consequence of the advice I have given.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">5.</TD><TD STYLE="text-align: justify">The conditions regulating Compromise Agreements under Section&nbsp;203(3)&nbsp;of the Employment Rights
Act 1996, Section&nbsp;288 of the Trade Union and Labour Relations (Consolidation) Act 1992; Section&nbsp;77(4A) of the Sex Discrimination
Act 1975; Section&nbsp;72(4A) of the Race Relations Act 1976; Schedule 3A of the Disability Discrimination Act 1995 and Regulation 35(3)&nbsp;of
the Working Time Regulations 1998, Section&nbsp;49 of the National Minimum Wage Act 1998, Regulation 10 of the Fixed Term Executives (Prevention
of less favourable Treatment) Regulations 2002; Regulation 9 of the Part&nbsp;Time Workers (prevention of Less favourable Treatment) Regulations
2000, Schedule 4 of the Employment Equality (Religion or Belief) Regulations 2003, Schedule 4 of the Employment Equality (Sexual Orientation)
Regulations 2003; Schedule 5 of the Employment Equality (Age) Regulations 2006; Regulation 40 of the Information and Consultation of Executives
Regulations 2004; and Regulation 41 of the Transnational Information and Consultation of Executives Regulations 1998 have accordingly
been satisfied.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">(Sgd.)</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 36%">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">Date</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 26%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>cycc-20230428.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaiLmbOdzZR+CYkxtmB5bSnqzyMsqCxm8CRFTuvmoYUF -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:cycc="http://cyclacel.com/20230428" elementFormDefault="qualified" targetNamespace="http://cyclacel.com/20230428">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://cyclacel.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="cycc-20230428_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="cycc-20230428_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="cycc-20230428_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>cycc-20230428_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://cyclacel.com/role/Cover" xlink:href="cycc-20230428.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cyclacel.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="loc_deiDocumentInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>cycc-20230428_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentInformationLineItems_lbl" xml:lang="en-US">Document Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>cycc-20230428_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://cyclacel.com/role/Cover" xlink:href="cycc-20230428.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://cyclacel.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="loc_deiDocumentInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiDocumentInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139637933740448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 28,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-50626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CYCLACEL
PHARMACEUTICALS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001130166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">91-1707622<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">200
Connell Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Berkeley
Heights<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07922<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">908<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">517-7330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CYCC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Preferred
    Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CYCCP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>tm2314647d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cycc-20230428.xsd" xlink:type="simple"/>
    <context id="From2023-04-28to2023-04-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130166</identifier>
        </entity>
        <period>
            <startDate>2023-04-28</startDate>
            <endDate>2023-04-28</endDate>
        </period>
    </context>
    <context id="From2023-04-282023-04-28_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130166</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-28</startDate>
            <endDate>2023-04-28</endDate>
        </period>
    </context>
    <context id="From2023-04-282023-04-28_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130166</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-28</startDate>
            <endDate>2023-04-28</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-04-28to2023-04-28">0001130166</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-04-28to2023-04-28">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-04-28to2023-04-28">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-04-28to2023-04-28">2023-04-28</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-04-28to2023-04-28">CYCLACEL PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-04-28to2023-04-28">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-04-28to2023-04-28">0-50626</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-04-28to2023-04-28">91-1707622</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-04-28to2023-04-28">200 Connell Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-04-28to2023-04-28">Suite 1500</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-04-28to2023-04-28">Berkeley Heights</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-04-28to2023-04-28">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-04-28to2023-04-28">07922</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-04-28to2023-04-28">908</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-04-28to2023-04-28">517-7330</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-04-28to2023-04-28">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-04-28to2023-04-28">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-04-28to2023-04-28">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-04-28to2023-04-28">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-04-282023-04-28_us-gaap_CommonStockMember">Common     Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-04-282023-04-28_us-gaap_CommonStockMember">CYCC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-04-282023-04-28_us-gaap_CommonStockMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2023-04-282023-04-28_us-gaap_PreferredStockMember">Preferred     Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-04-282023-04-28_us-gaap_PreferredStockMember">CYCCP</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-04-282023-04-28_us-gaap_PreferredStockMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-04-28to2023-04-28">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MCM-I4XK@N4[IILXI@)/8ERJ1*F,[)S,-Q4"D(IY<PX3"O,J@,NHUZC=C#/+
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M3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ;
M 4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " #-@*16EXJ[',     3 @
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MY68R#/; @L4?>M>9_+2'V#-B#Q]6C>1FEJE@A1REW^CUK7H\@RX/J!5Z0B?
M:ROPS-0V&(Z=C*9(;V+T/8SG4.*<_U,C5146L*:B]1!DZ)'!=09#K+&))@G6
M0VY6= ;N\N@#FW+()FKJIBF>HPYX4P[V1D\E5!B@?%.9J+SV4VPYZ8Y>9WK_
M,'G4'EKG5LJ]AU>RY1AQ_)[E#U!+ P04    " #-@*16)!Z;HJT   #X 0
M&@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I
M0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LID
MR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\
M./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6
M?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ S8"D5F60>9(9 0
MSP,  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F
M&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\
M% )5!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY
M&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J
M>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q
M32:>,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1
MS>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4
M    " #-@*16!T%-8H$   "Q    $               @ $     9&]C4')O
M<',O87!P+GAM;%!+ 0(4 Q0    ( ,V I%8S@C9X[@   "L"   1
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M96QS+RYR96QS4$L! A0#%     @ S8"D5JK$(A8S 0  (@(   \
M     ( !^Q   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( ,V I%8D'INB
MK0   /@!   :              "  5L2  !X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<U!+ 0(4 Q0    ( ,V I%9ED'F2&0$  ,\#   3
M  "  4 3  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  (H4
$      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2314647d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyclacel.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2314647d1_8k.htm">tm2314647d1_8k.htm</File>
    <File>cycc-20230428.xsd</File>
    <File>cycc-20230428_def.xml</File>
    <File>cycc-20230428_lab.xml</File>
    <File>cycc-20230428_pre.xml</File>
    <File>tm2314647d1_ex10-1.htm</File>
    <File>tm2314647d1_ex10-2.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2314647d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2021q4": 26
   },
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "cycc-20230428_def.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2314647d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cycc-20230428_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cycc-20230428_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cycc-20230428.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 65,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 2,
   "nsprefix": "cycc",
   "nsuri": "http://cyclacel.com/20230428",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2314647d1_8k.htm",
      "contextRef": "From2023-04-28to2023-04-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://cyclacel.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2314647d1_8k.htm",
      "contextRef": "From2023-04-28to2023-04-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock [Member]"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cyclacel.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001104659-23-056001-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-23-056001-xbrl.zip
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M>#GVWIGUGYO=-B5C)1MB_W?>T!SYOTN')O)R:]3=1-,,_P-02P,$%     @
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M35W\HSZ7'S>_S/\4TD?^"U!+ P04    " #-@*16T,-M%K(+  "7D   %0
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M&]YBLM7^-4U8&+2-P334M!X[^3NR2K*<JX&GFL5T=&F WO4PT&G;'!>LXB#
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M(LDBG!9^+L2VKB<V%JUK2$"[)B@M85"P0.Y 8(H S8T*\0[-/PGFPY"I*?T
MT[)JQZ62!0B+Z:T/%:GW!LK9AO.&<WCT@:6N4.DSJUF!=$' TF.N]3I2(6_
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M.^TN!):8)1G5&[5AIPA>):H[X;BL2+</C2PAB087G:4;A+IGI7/5EOJ8(XM
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M7-KIU'1S@15$TOB0J.UAL3J!+E@6:E+= \MBV2(OTN=4M +(_&H$O)F0B7H
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M(AMXE-DP_)R2<(T;%F[]D6]'5Z?@?$N#@R=/7VMM6N%+B%_F?<:3.P#%/SL
MKW)L9[5.;?BMPHT/YX?7-U>K>K?QS/G>QB:V/.8@\IA^R<QB9]1EBO\J>LK5
MZ)M#(K8:#!D5RU=\^K$ZIKSD1C*&T2W:U<QVL+\KTB=^ ]R;H'T+ZZ'%@%K?
MZ]HNF'OC+>PZOKT@!]QI7*S>9]31O#XH>_'C1@LXE\&[+LF45UU.\9'#B]+R
M5]S,AWQ$HZTYWO<"0Y3FC1%,58BV>PF\YG'D:(C7PC_C5K1?GSK/\U/J>UZ6
M\4]=YM$LZA> 8ME/KN8L"SI>KC*';K].EW709#D(Q1U)>R^$_K1C9=G@4-F:
M2/)K1F$>ME,.R(4.Z,7.R"V!_YOVG_&MUGOD3!N24O!*ZQ<Y*O=*_GEI'U@E
MMAKVY*M4WHR[_GJ^<[YE&T.1*(:XVJQ$"=:D@(VTG -CL$\:-?'AME ^NA57
ME<@-, &<Z$<_#8[OC,))Y_[P<_='_M 8W*D7]T/S8[XQ//E^SS^SYO:W;R<G
MGPSU2C6^/=Q_<T^_L!NMUGGZ^6.GM/7Y?E!OFMZ7AGYN6E^-S]_/E9L".[VG
M]?,/[9LOQ7OZ4SUK,5I2"C^&RFGK>WMX5+V^__#Q^K+X9??4ZY:]BP_-P5WU
MJ'4]K/;JWX^^79K6X7;U)%^L[S:*7[03M6E^[QB?[RW'_O[E*[<>RS=GW6_;
M3:?=V?WT0VW>-<_TSW_Q8[L]/#QYZK +Y>S>*NOGAR;[5NT]_339CZ;3:C]\
M5TSV\/W+>7>G=7K&+G?,]N>/UE_U^P=)CO\'4$L#!!0    ( ,V I%9C!U_4
M,DD  "N' 0 6    =&TR,S$T-C0W9#%?97@Q,"TQ+FAT;>U]Z7/;1K;O=U;Q
M?\#SNS,EW8)L25X26QY7R;8R<2:)7;8R>5.W[H<FT"01@P 'BV3.7__.UAL
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MRZVY',,PE7P53RN3 TG[7R:!U]U<.&PSZ'CDC2K*;Q:(/CAC<;O16? SY)M
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M7Q!?PC+&(RZ*857,,W_8O8C1-7PQD"'H;':.O;'(L0X*E]LH[T,T93&*J3^
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M&,9ZZ=JR;&/O#2. TQX^%2D%:%>3'F6!982:'_, NU:HAVA?C,UW9IQVPS3
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M)&2A+ *R=TM@JM<@EF9?EP[?YB=3WG0?U><U6;K01^4.I9=)L1V/E7@I!^G
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M#XEMR[0H4R[^'NJSX_<,)X_3P%0I_VB:4V81P^'1=9*K\XX-XL%/[L9B&"V
M%<+.)#AT5E7ZK&2(E*#Z:5._%1OSESJN-E$ )&"&D##2SPQW%0-9T4#'W,RX
M<XO2[WL+-!,@GM1:O\=_%\ T,_$/E],I]CT8IO[H8XC_"M^R'R$(M^-Q^@'Q
MC1T98U2_HRFNU>/Z_5>F*A.]SO%QJ()VY0(\9,4"$$%ARM<XE%W7IL6WWU69
MD&"["*B,6[M0[[D/#'5V2W58^V>8S34O)BLGSS5"EN/D*2R^\N"-.Z[9N-/.
MV";J>.68)?4Q&ARZZXT8[@IE9 E/D^7Z,!?Z,_&;)\L&9G7=Z@"F]]N@_#_1
M2_9;SSV&5[WH!EU;S(OV]^TPER,E1$;ED&3B!";9@!"U!9JD?]2Z.M.,L<\P
MP"%+.++'MZYWH5D:M%#[^+R8/UW(+)/SP6WMQ-TFO8G$:&NZL.;&?6B;6W+%
MKRN2]%' 6/])78O''J[57*7<E<'A^7BKH2"(X#Y1'*5;=L]-'2BV8<Y'P->K
MLTS TWV5@O:W*(L]AT0VL-ODMC* -)S0QLL>C_@^QW92MB''!&]S^(:8C1&1
M5L24M1[$YL'AH9]A'(=@)"KZM2P<8DTP9%D$1168.$P6L[:MIR3!*B22"V__
MFRQ09#!NG@'*Y1.XN[ T';2^.\\.]N]NP]QX+A;'E/J;@D(+/,:PUL^?W>VV
M1O-SPN>:BYFH+^\P@!O%]!S>.4HJS130]>10!P&X[50])\+FR&T%&UX4NHK'
M(P%6][HF1'[3A#0[:W,$T,)*76R5*7E)"[B[$J+&TNM&$6,RVB+N-E5A46H;
M6))5M+)SXZD@GZFF+KE42:K9[=[!LSAS.R*<7$J%/95FGVKB)5W9%W6<G2Z+
MM?<8N[ R"TJ'<&_K<E[-]Z4)JZ?*>)W+*/%1+;1+'N,$WP2H&;B]JDT5-HDL
M9=(\,6-88 M@E7-$6>/?N6,JBCO,7N04/1%XIC=S,B^R?[?X^P(,"2S1PH=6
M8/BP.49)94OMC@4V7LVDBP-MN,R-NM"4-;8@,(<W'KG=LJH+-@<6_YD['"R.
MJVB/\7U3D$8%]?> CQM:=E <8CN5^D.L/\X@<3RF-S#UX/KLVO@#\7=7W3>!
M#%4F5[!WMV/QQJQ2R[D7 4!G^BJPK;W)8C,"9@SK?)<FA*IPFNJZWLK=NXK3
MH;$1!\P%R^Q0 84+?*)S;(U,XL&HR/Q:5$ZSVD+63SA9%)8*/W09X,@SW?W]
M-A?*L@53+HG>%^4Y& /HV_+4+O\+V)5'F[L[3&@GQ89VW":+N!XG)95FK@DY
MFF,FN4!>1-P=Z0? JW:/>'""E).<+3/Q!G/30O^ C&SM9DBK0,(0&SM3UO:I
M0*^UJDQY@@AHQ!C'W3D;V!R@.+N#Z"N8MEQ6R:D:P$C=0"HG;R#]5:GT73J?
ME[$0 QE5:8NY)>CE60T4J$J7JTG9%M)M(Q"=7*,$5(Z=#$*".Z(PU<[0,AQ9
M"]BBWS8!-QK=(,C+M=P=TNG#0<""!84=K4V?<&-J_@'76)UF@HQY9I =KD/H
M:3-/^N.;Y4E_?.M)_R:TWH/M:;VOBC.N3*T]A=?>GJ?#Q5;K,E&H5S8EV4OU
MPY .Q$(.170,-LZD3$61-8JH9J5BV6#3*5*5RKR<K22>)\.QHO8^$Q?PF5<F
MY95K45U:.ZG!ZE25-.]S95M#5O^P;DU L9*_1SFX9SH'%28-_<)^9Z,^^--
M/;T#I]J1E-\W--ZI7;2K7@VF"1=E70/MT;T-XR]UTXI[RIK2!2>(22\=YV:
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MR1BQ8+3!E-FZAA<N5_2WF%T+0-_OG9^A(.A"AP W-56['#DLX5FY1881ZBW
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M\X-1H?4$WO^7@O[>#I(2IA[K0)5!/@S^KK*9*N:\'7MAL+^[_R@8S .5Q<%
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MG8'&:_\,=%/<5W^*/W5,$??*7[=W8/[YUU[ISPWGS"=R&RGN$O+DZP1*0XB
M\ ">4Z;BQ4%%&=3X>%88SMS2EH$9L.@118"8"C!?= Y9?0G8!,Q:_@H-ZT7N
M N)?E6.2]068(6 ^(D=#/89L%/HK-XR.1T"K6<7 5_ ?+,TTB")T<<U2%%KT
M[ZH \PQG759Y]!DU3V97\NX<%E/0#(CYB1 P4P/3E;ZWTHX8I$A)S=8^[0PN
M/I^!5BNK!X9'X35@QF"B=C,\,3-)?2-)!*O=4G**$ST9X$2':&F::;!@@,\.
M90.(G:J K/V"=-V63-H:R(@JJ(V)WTW@GO&@96/4(C@M@-CPY/D-5NK!7&JO
M4!@EFHNM#,=!8@)V 86LE6B.L&!O6.#QSCAQ!QN._NHX*5$/)W<)>4E:'DO0
M<D&-Q(D8447J\G16T4^V5+J-^H>FSTG3*8#]P-)8#4!9R+MI*+2I#M]B =3)
M#GYX6;=44,DA;P7>.!+[J&7@37J=@E["4WH$BH <M_&R-QT5?"[L5R+/E&;%
M3%7T\_W=_<?HYD%_P41K-*C89N+GB!?,2DVG.H!M]I7"2.$WK"D8P]ZZB=Q*
M\)@TD\&0/!HZY6O47H[E"4;G=+,';0A,TY(&1+<G:JMHPA3B%8&_V/[IWAXR
MI<P\69TF/Y=C)R5[_&1N="72G/>\OAZZYF2=N<]6,WO_2:J;LW:#=85EQ-J=
M92DI\XT 390BVV-]TC^IAE?(;/>#X* 4_3E-A=W8VT6_6.32$Q>C<H=KSU-N
M;QG4#]]\W^\)&ZD=R/E89WC$0?T4V12B@1S_\1]\$!PWB3#2JN0HE>72-Q N
M&XHY ?1?F@"X(VOO8N#V$!,C.52;.EG=P"G*QHXN.1!CYX,\B<%\T<ZCN'B(
MN\8ONQUDC]?L('L%5-/OG:B47$K&+68<U;S-4V5=2'Y4!R13@A9W,( Q@I*&
M8"^JX;<%&EIP!G^9(J]XOO_X<?C3_GX8>)YMD+(@&\E.33)0$+18YDYOJ]07
MNJQ(^D"(XF)"$Y_$H]R[V/<\_1?^A$FC2@7< 0QC<3=E<6VDAN_,!:=I*?V>
M=<K"6#1#H=P2K CAR9A5HLJD-$S4;!P\P8%M,PU@12.XZX5*X>YF4<&W=6%\
M7#9P0*<C6[M4K36!!-(H,%A#.@W.$4^._-<P5NQB!84^2X X:=>,:>\I&#HK
MF<NAJSNI*@R1^K>I&9?I>,!FN02'2V:^B-7Z1$5TQ*<!*ANP4IP^'"LR1YWF
MYS1$%S72@];?8/T (0Q3R*-X6HD<2-Q^F-A5<W/AL,V@[ Z044753FJ,"\Y8
MO(IT%OP;\M.@V1)C]$D[S3U*BF@V0>\29D>@[P@9FI .<(0))AOAY Q9"PU1
M+,T=@AR5-MMZUY7';F;X9,W,\(!N7;\'%Q3=A&=XAMG,"Q<<H^W <>@61^RD
M7(]2 C7(,6169Z/6#0K+17-!)*HP #A5,#>1/F4^ YR/1&Y!V8E4"MJN*H*Y
M5E;:M:X8\SGW**N1]7E@0HL_!1J>%"H<&GV#/$_F(JC= &,N1KI"OQO.#OT3
M,@'X_\SH]OYN& =^^T'+:>&RI7 3J^#)[H\X7&MW^[U%H_,J8]T1A%,3D#_6
M?RR\M7-GZ\NTS!)O53E4D37NG*\1C@A43/11!J#?@)A(RK%3VKHY8Y<5F<GK
MC%^ /K7.34_NL@P::+@QY)B%Z>!A]7M$ ^1#=>*5UMM@[Z(#'^JI6$IY0PJ5
M-5^J&JDD*ZN6C]4LFRD:]H8BLLO(5M@HFO/ *_^#OX<I K&)4J\DC8K(XT%P
M0L&BCC?R*4E8QR9@UF<WRE5:DNT-TAF=_FXOFP:DY;W3%&9@0CZXFV0CG6MX
M&::IP6;!1<99Y[2_M%/FYVTV4*,17XR4>JIHOBBC.2K%B:2UJ887SY4I'N-1
M:9WN61W)_8.QN\3ZE;>8A6==Z!V?HFE'V2]AE^\4_OH5X_,&W0?#"20 4Y[8
M.)F:.&"_Y[TYM#>/<GE7NCUE#KS*72'8C5R$'FVBKXYAJF[<RDLB%@#:!$XV
M=/,.48"+RA<ZU@2\-IJE9%OCHJ<J03=:@)\40KSG.>M3 3PS!#K/JG'IY5W@
M&_CGLDU1FI>&:^*=$68.)&4F/H3EP1G1U89]8_Y);)FWF#96E[=8G*\6C-B_
M7W&'_4W<X:9UQ9_6G0_IW!>O0#L? D=R>F+=TVE9"$K#*F7G7*$C32$,+TM,
MQB&O/J5"$E->++CX]\$4B#M*- 62Q4AACZ+.$E3EG%R7\$-L#,_?,_+]_P.X
M4PSV8LMH#$7*4FC;A(<I=T+<ZC:8C7R:0J@@ET)@[45RAB(._3/ P,( SX+T
M@QB>'R(/+V<%<WY8:B)?QUJ1Y"O4F4[M%R'[*<FY"_Q>27*&-P0H.+@1);K_
M)3\8'P&YB\\X/01G!Z2T_R0XSPN*<<=HJ*-&A^S\3$7*:F-[N_;+W_\13&<@
M!R-,"4KH4U9T,#H$HM87DQV&]YR4UN_+]/IY[=<)*<A+S>KW3CT!SE>HT,ED
M,"O*1EX?VTST/7HAV54#)YAI=*BC&:9E="2%&:77@88Q3B:2:YZ)Q[8KEX#<
M'IA,8$L6C,IGYD9J.^C<DZ0LQ3Z0]TDB%FM-<0Z&/9*YL=I7N>+F:C^H;P=J
MDN)1M08I7I_:*R@B,IP5Y":#&0'M*V.YNH092EVT.\3KJ"I.]W4;/J%K",M
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M,MDJ4ZXJZF )_'JJ(^ +^JY'L3@)2*TAJ12V^[4ND!;ZO4/8IXQSBHGH@C=
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MIZ=":QVU,,FLAK&V/=GIUW&(M^&D0I=EV.& L-GI_$!2F&M!MGN.-1X11A?
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MAD-5CHGW<U"HD%,-P4)C..5%:'!Q<C9+1SJD7M(INLTX-CP!KA115@*[LSA
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M/=1I+ !3B!U;Y(/R?K9,,3Z#A:(7BOH<)-Q>JZXL!ZB+<H34<Q0'=5@<>KM
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M57_['><[1G/X.J@#UAP.I(( LTA/#=S^B<FUQC]^0U< ?X6;^KK6U,!1P;)
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MGQ)?>0:"OZSN1]3AY]6C#C<7 GCXZOWAO\A=_.OI;V]?_G]02P$"% ,4
M" #-@*165Y!E"TL#  #D#   $0              @ $     8WEC8RTR,#(S
M,#0R."YX<V102P$"% ,4    " #-@*163NAQ%]X(  #0:@  %0
M    @ %Z P  8WEC8RTR,#(S,#0R.%]D968N>&UL4$L! A0#%     @ S8"D
M5M##;1:R"P  EY   !4              ( !BPP  &-Y8V,M,C R,S T,CA?
M;&%B+GAM;%!+ 0(4 Q0    ( ,V I%;A9ZIE+@@  &AE   5
M  "  7 8  !C>6-C+3(P,C,P-#(X7W!R92YX;6Q02P$"% ,4    " #-@*16
MY_9DU:,9  !FF   $@              @ '1(   =&TR,S$T-C0W9#%?.&LN
M:'1M4$L! A0#%     @ S8"D5F,'7]0R20  *X<! !8              ( !
MI#H  '1M,C,Q-#8T-V0Q7V5X,3 M,2YH=&U02P$"% ,4    " #-@*16)NE,
M-N!2  !>&0( %@              @ $*A   =&TR,S$T-C0W9#%?97@Q,"TR
:+FAT;5!+!08     !P ' - !   >UP     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
